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ABSTRACT 
Among the three functionally characterized vesicles within the cell (Clathrin,  COPII and 
COPI coated vesicles), COPI vesicles mediate the transport in both anterograde and 
retrograde transport within the Golgi complex (Orci et al., 1997) as well as recycling of 
proteins from the Golgi to the ER (Cosson and Letourneur, 1994; Letourneur et al., 
1994). An in vitro based assay using soluble coatomer and ARF1 together with synthetic 
liposomes containing p23 tail peptide yielded generation of COPI vesicles, thus 
establishing the minimal requirements for COPI coat assembly (Bremser et al., 1999). In 
a program to reconstitute one round of budding, uncoating and fusion of a COPI vesicle 
from defined components, the next step is to include in a liposomal system the 
components needed for the fusion reaction. For that purpose, SNAREs (Soluble N-
Ethylmaleimid-sensitive fusion protein Attachment protein REceptors) were required 
since they were shown to be the machinery for fusion (McNew et al., 2000; Nickel et al., 
1999; Sollner et al., 1993; Weber et al., 1998)). To study their behavior in the COPI 
budding process, different ER and Golgi SNAREs (Sec22p, Vti1p, Gos1p, Bos1p, Bet1p, 
Ykt6p) were produced in bacteria, purified and reconstituted into liposomes in their 
correct physiological orientation. Sec22p and Vti1p do not seem to be preferentially 
taken up in COPI coated vesicles under the conditions of the in vitro budding assay. 
Preliminary data allowed reconstitution of SNARE complexes and further experiments 
should allow the study of the mechanisms involved in their specific uptake in COPI 
vesicles. Prior to fusion, vesicles need to be uncoated. This process was shown to be 
dependent on ARF1-GTP hydrolysis (Tanigawa et al., 1993), a reaction catalyzed by 
ARF-GTPase activating protein (ARF-GAP). Therefore myristoylated yeast ARF1p as 
well as its ARF-GAP (Glo3p) was produced in bacteria, purified to apparent homogeneity 
and in an active state with regard to exchange of nucleotide and GTP hydrolysis in 
presence of liposomes. Moreover, selecting for large size liposomes used in the in vitro 
budding assay was critical to ensure newly formed vesicles are authentic ones and not 
preexisting small structures. Therefore, gel filtration experiments were successfully used 
to achieve this goal. Tools were provided to reconstitute one round of vesicular transport 
in vitro. Active proteins (ARF1p, coatomer) involved in coat assembly, ARF-GAP 
required for uncoating and the fusion machinery proteins SNAREs were provided. A 
Homogenous population of large liposomes was generated so that the total signal 
observed after budding is due only to de novo generated COPI vesicles and not to 
preexisting small structures. 
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1 Protein sorting within the eukaryotic cell 
 
For a cell to function properly, each of its proteins must reach the 
correct cellular membrane or aqueous compartment (the mitochondrial matrix, 
chloroplast stroma, lysosomal lumen and cytosol).  
Hormone receptor proteins, for example, must be delivered to the plasma 
membrane, soluble enzymes such DNA polymerases must be targeted to the 
nucleus, while proteolytic enzymes must go to lysosymes. Other proteins such 
as collagen or other components of the extra cellular matrix must reach the 
cell surface and be expressed there. Thus directing the newly made proteins 
to their correct localization is critical to the functioning of eukaryotic cells. 
The secretory pathway consists of separate membrane-enclosed 
organelles that lead to the cell surface. Newly synthesized proteins destined 
for secretion enter this pathway at the ER. When the ribosomes synthesizing 
the secretory proteins are bound to the rough ER, the proteins cross the ER 
membrane cotranslationally. Then soluble proteins are sorted to the lumen of 
other organelles or secreted while the integral membrane proteins are either 
permanently inserted into the ER membrane or eventually localize to the Golgi 
apparatus, the endosomes or the lysosomes or the plasma membrane. 
Secretory proteins and enzymes on route to the ER, Golgi, lysosomes 
and plasma membrane proteins are synthesized on ribosomes attached to the 
ER. All proteins entering the secretory pathway contain a sequence of 
hydrophobic amino acids at the N-terminus that directs the ribosomes to the 
surface of the ER. This ER signal sequence is recognized by a signal 
recognition particle (SRP) that binds to an SRP receptor on the ER 
membrane. The SRP directs the insertion of the nascent polypeptide chain as 
well as the binding of ribosomes to the ER membrane. GTP hydrolysis by a 
subunit of the SRP, P54, and the α-subunit of the SRP receptor provides the 
energy necessary for this process. Nascent proteins cross the ER through the 
translocon, a multiple protein complex composed of Sec61 complex and 
TRAM protein.  
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Once membrane proteins are inserted into the ER, they adopt their orientation 
in the ER membrane that will be kept during the transport to their final 
destination. This phenomenon involves topogenic sequences that are either 
an N-terminal cleaved sequence, a signal-anchor sequence, a stop-transfer 
anchor sequence (transmembrane domains) or a GPI anchor attachment 
sequence. 
Before reaching their final destinations, newly synthesized secretory 
proteins are modified in the ER. Disulfide bounds are formed, correct folding is 
accomplished, sugar chains are added and the protein may be assembled as 
a multimer.  
Disulfide bounds are formed and rearranged in the ER lumen. The oxidative 
local environment in this organelle allows this modification to happen. 
Cytosolic proteins lack this modification. 
The correct folding of proteins within the ER lumen is a crucial step since only 
properly folded proteins can continue their journey in the secretory pathway. A 
folding quality control step involves the combined action of several players 
such as protein disulfide isomerase (PDI) that accelerates the rearrangement 
of disulfide bounds, or peptidyl prolyl isomerases that catalyse the rotation of 
peptidyl-prolyl bounds in unfolded parts of the protein.  
Chaperones like Bip bind to proteins and prevent them from misfolding or 
aggregating. Eventually, misfolded proteins accumulating in the ER are 
transported back to the cytosol through the translocon and degraded in the 
proteasomes.  
Resident ER proteins like Bip and PDI are retained in the lumen of this 
organelle to carry out their function. When ER resident proteins escape the 
ER, they are retrieved back. This is accomplished by a C-terminal sequence, 
KDEL (Lys-Asp-Glu-Leu) that targets them to the ER since this sequence is 
recognized by a receptor at the Cis-Golgi, Erd2 in yeast or KDEL receptor in 
mammals.  
 
 
 
Introduction  5   
 
1.1 Protein sorting to mitochondria and chloroplasts 
 
Mitochondria and chloroplasts contain organelle DNA that encodes 
rRNA and tRNA but only a few organelle proteins. Most of the proteins are 
encoded by nuclear genes, synthesized on cytosolic ribosomes and then 
imported to these organelles. 
A Specific N-terminal uptake targeting sequence allows the proteins to reach 
the mitochondrial matrix or the chloroplastic stroma. The process of import of 
these organelle proteins is regulated by chaperone proteins and proteases 
that cleave the targeting sequences.  
The energy required for translocation into the mitochondrion matrix is given by 
ATP hydrolysis and by an electrochemical gradient across the inner 
mitochondrial membrane. This gradient is maintained by the pumping of H+ 
from the matrix to the intermembrane space, driven by electron transport 
processes in the inner membrane. 
 
1.2 Protein sorting to peroxisomes 
 
 Unlike in mitochondria and in chloroplasts, the total of peroxisomal 
proteins is synthesized in the cytosol, since no DNA is present in this 
organelle. All peroxisomal membrane and matrix proteins are post-
translationally incorporated into the organelle as folded proteins. Peroxisomal 
proteins bear a targeting signal at the C-terminus that is a Ser-Lys-Leu 
sequence. The energy required for the peroxisomal import is provided by the 
hydrolysis of ATP. 
 
1.3 The Classical secretory pathway 
 
To exit the ER, secretory proteins are taken up into COPII vesicles, that 
fuse together to form the ER-Golgi intermediate compartment (ERGIC). At this 
point, ER residents are recycled back to the ER in another set of vesicles, 
COPI, and the cargo proteins to be transported further enter the Golgi where 
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other enzymatic modifications occur. Finally at the trans-Golgi network, cargo 
proteins are sorted to different compartments such as the plasma membrane, 
endosomes or lysosomes. 
The Golgi complex is the central organelle of the secretory pathway. It 
consists of stacks of flattened membrane-bound cisternae interconnected to 
form a ribbon (Marsh et al., 2001a; Pisam et al., 1990; Rambourg and 
Clermont, 1990). Each cisterna contains different resident enzymes that 
process the forward trafficking of cargo proteins by glycosylation, 
phosphorylation, acylation, sulfation, and enzymes for the synthesis of lipids, 
sphingolipids and glycolipids. 
Transport of cargo molecules in the secretory pathway involves at least three 
vesicular carriers. COPI vesicles traffic from the Golgi to the ER and between 
Golgi cisternae in both retrograde and anterograde directions. COPII vesicles 
traffic between ER and Golgi, while clathrin coated vesicles travel between the 
plasma membrane and the early endosomes, from the Golgi to the 
endosomes and from the trans-Golgi network (TGN) to the plasma membrane 
(Figure 1).  
On the other hand, coat independent pathways arose in the last years that 
show clathrin-independent endocytosis to the TGN (Nichols, 2002) or a 
transport pathway from plasma-membrane caveolae through an intermediate 
organelle (called the caveosome) to the ER (Pelkmans et al., 2001). The 
focus here will be on the three different classes of coated vesicles that have 
been so far characterized at a molecular level. 
COPII vesicles were first identified in the yeast Saccharomyces 
cerevisiae (Barlowe, 2000; Springer et al., 1999). Newly synthesized secretory 
proteins are sorted into COPII vesicles. Three cytosolic protein complexes are 
sufficient to drive the COPII transport: Sec23p-Sec24p, the Sec13-Sec31 
complexes and the small GTPase Sar1p (Barlowe, 2000; Barlowe et al., 
1994). 
The cytosolic Sar1p in its GDP inactive form is recruited to the ER membrane 
upon exchange of GDP to GTP (Barlowe and Schekman, 1993) via the 
interaction with an ER attached protein Sec12 that is a Guanine exchange 
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factor (GEF) for Sar1p. Sar1p-GTP now bound to the membrane recruits the 
Sec23p-Sec24p complex to members of the p24 family proteins, putative 
cargo receptors, through a cytosolic FF motif, and to v-SNAREs Bet1p and 
Bos1p (Peng et al., 2000; Springer et al., 2000). Once sar1p and Sec23p-
sec24p are in place, the second complex Sec13p-Sec31p is recruited and this 
growing coat scaffold is thought to deform the membrane leading to budding 
of vesicles. GTP is hydrolyzed by the action of one coat component, Sec23p 
that acts as a GTPase activating protein (GAP). The coat is dissociated and 
all its components are ready for a further cycle.  
Clathrin coated vesicles were the first vesicles to be identified (Pearse, 
1975; for review see Kirchhausen, 2000). At the trans-Golgi network, ARF1-
GTP activates the recruitment of clathrin coat to the membrane whereas in the 
plasma membrane this activation is not well understood. ARF1-GTP recruits 
Adaptor Protein-1 complex (AP1) to trans-Golgi membranes where it binds to 
membrane receptors. ATP, GTP and phosphoinositides are necessary to 
recruit a second Adaptor protein complex (AP2) to the plasma membrane and 
endosomes. These two adaptors bind to sorting signals found in the 
cytoplasmic tails of many transmembrane proteins, e.g dileucine motifs. Coat 
assembly starts then with the recruitment of cytosolic clathrin to AP1 or AP2 in 
a nucleotide dependant manner.  A coated pit forms with the polymerization of 
the clathrin heavy and light chains. At the neck of this forming pit, another 
cytosolic protein, Dynamin, polymerises around the neck and hydrolyses GTP, 
allowing the clathrin vesicle to pinch off (Takei et al., 1995). 
 COPI vesicles are involved in transport within the Golgi in both 
retrograde (from Golgi to ER) and anterograde (within the Golgi) directions. 
Their composition, biogenesis, and function will be addressed in the next 
chapter. 
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Figure 1: The three major types of transport vesicles, COPII vesicles transport proteins from the ER 
to the ER-Golgi intermediate compartment and to the Cis-Golgi. COPI vesicles are involved in the 
forward transport within the Golgi and in the retrograde transport from the Cis-Golgi to the ER-Golgi 
intermediate compartment to the ER as well as from the trans to medial to the Cis-Golgi. The clathrin 
coated vesicles are responsible for transport from the plasma membrane and the trans-Golgi network. 
The question marks point to recent research that has shown a possible coat independent trafficking of 
caveosomes from the plasma membrane to the TGN and to the ER.  
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2 Golgi vesicular transport, a focus on COPI coated 
 vesicles 
 
2.1 Recruitment of COPI coat components to the membrane 
  
 Whereas COPII trafficking is unidirectional (ER to Golgi), COPI 
trafficking functions primarily in retrograde transport (Golgi to ER) and is also 
important in forward transport within the Golgi. 
The COPI coat is made of the seven subunits (α, β, β’, γ, δ, ε and ζ-cops) of 
the coatomer and the small GTPase ADP ribosylation factor 1 (ARF1). 
Recently, novel isoforms of COPI subunits were identified (γ 2 and ζ 2 cop) 
(Futatsumori et al., 2000) that define three subpopulations of COPI vesicles in 
higher eukaryotes (Wegmann et al., submitted). 
ARF1 exists in the cytosol in its GDP form and its recruitment to the 
membrane depends on the exchange of GDP to GTP, a nucleotide exchange 
that is achieved by the action of a guanine-nucleotide exchange factor (GEF). 
This protein is the target for the fungal metabolite Brefeldin A (BFA) 
(Donaldson and Klausner, 1994; Helms and Rothman, 1992; Robineau et al., 
2000) and its action causes a redistribution of Golgi enzymes to the ER 
(Lippincott-Schwartz et al., 1998), arrest of COPI vesicles formation and the 
redistribution of its coat components to the cytosol. 
The association of ARF1-GTP upon nucleotide exchange to the membrane 
(Rothman, 1994) was thought to be the initial step in the coat assembly until it 
was recently shown that ARF1 in its GDP form interacts with the C-terminal 
cytosolic tail of p23, a member of the p24 family proteins, before exchange of 
nucleotide (Gommel et al., 2001). In consistency with this finding, recent in 
vivo data showed an energy transfer between p23 and ARF1 tagged 
respectively with CFP and YFP under ARF1-GTP hydrolysis conditions 
(Majoul et al., 2001). However this interaction does not seem to be a basic 
prerequisite for nucleotide exchange since the GEF mediated nucleotide 
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exchange on ARF can occur in the presence of liposomes and in the absence 
of additional proteins (Beraud-Dufour et al., 1999), or even without an 
exchange factor. 
The p24 proteins are highly conserved type I transmembrane proteins that 
cycle in the early secretory pathway where they are involved in COPI coat 
assembly (Bremser et al., 1999; Jenne et al., 2002; Sohn et al., 1996). They 
are assumed to be receptors for COPI since they can bind its components 
(Dominguez et al., 1998; Sohn et al., 1996). In fact, the cytoplasmic domain of 
p23 interacts with the γ–COP subunit of coatomer (Harter and Wieland, 1998) 
and recruits ARF1-GDP (Gommel et al., 1999). Moreover, they are part of the 
minimal machinery for COPI budding (Bremser et al., 1999). The topology of 
these proteins consists of a luminal domain of about 180 amino acids with a 
predicted coiled coil domain and a short cytoplasmic tail of 10 to 15 amino 
acids that in some cases contain a K(X)KXX motif for Golgi to ER retrieval 
(Dominguez et al., 1998; Jackson et al., 1990; Jackson et al., 1993; Marsh et 
al., 2001b; Sohn et al., 1996). Since the identification of the first member of 
this family (Wada et al., 1991), six members were then identified in higher 
eukaryotes (Stamnes et al., 1995) and eight members in yeast (Emery et al., 
2000). These proteins were shown to be present either as dimers or as 
monomers (Jenne et al., 2002) in contrast to other data, where they were 
described in a higher oligomeric state (Dominguez et al., 1998; Marzioch et 
al., 1999). 
The interaction between the p23 tail peptide and ARF1 might play a role in 
regulating the ARF1 retention at the site of budding. It was shown that upon 
exchange, ARF1-GTP dissociates from p23 (Gommel et al., 1999) and thus 
priming the membrane for coatomer recruitment via interactions with ARF1 
(Zhao et al., 1997; Zhao et al., 1999) and p23 (Dominguez et al., 1998; Sohn 
et al., 1996). In addition, coatomer was shown to stimulate ARF1 mediated 
GTP hydrolysis 1000-fold in an ARF-GAP dependent manner (Goldberg, 
1999). Therefore a tripartite complex formed by ARF, ARF-GAP and coatomer 
was suggested. Moreover, the cytoplasmic domain of p24 inhibits coatomer 
and ARF-GAP dependent GTP hydrolysis (Goldberg, 2000). This down 
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regulation of GTP hydrolysis was proposed to enable formation of priming 
complexes providing a time frame where coatomer remains attached to the 
membrane long enough to allow polymerization of the COPI coat, leading to 
vesicle formation. 
 
2.2 COPI coat formation 
 
Coatomer and ARF1-GTP polymerization is likely to provide the mechanical 
force needed to pinch off a COPI coated vesicle. Polymerization of coatomer 
and ARF1-GTP deforms the shape of the membrane and eventually results in 
the formation of a vesicle (Malhotra et al., 1989; Orci et al., 1986). Studies 
using coatomer and p23 and p24 tail peptides allowed understanding the 
mechanisms underlying coat polymerization on the membrane. Usage of 
homodimers of p23 and p24 tail peptides resulted in aggregation of coatomer  
on one hand and in a conformational change of its γ-cop subunit on the other 
hand (Reinhard et al., 1999). Knowing that this subunit interacts with p23 tail 
peptide (Harter and Wieland, 1998), this study has established this interaction 
to be crucial for COPI coat formation. 
However in yeast, knock-out of all known p24 family members in a single 
strain did not result in any severe effect on vesicular transport (Springer et al., 
2000). In contrary, similar p23 knock-out in mouse was lethal at a very early 
stage of the embryo (Denzel et al., 2000). 
 
2.3 In vitro generation of COPI coated vesicles from 
 liposomes 
 
Coatomer, ARF1 and p23 tail peptides were hypothesized to be sufficient to 
trigger the budding of COPI vesicles. An in vitro budding assay was 
developed that used p23 tail peptide containing liposomes resembling in their 
lipid composition the Golgi membranes, ARF1, coatomer and nucleotide 
(Bremser et al., 1999). Under incubation at 37°C, coated vesicles were 
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formed that resemble in their size, morphology and density the original COPI 
vesicles derived from Golgi membranes in accordance with previous 
experiments using Golgi membranes to bud COPI vesicles (Orci et al., 1993). 
In such a minimal system, the core components needed for budding were 
provided. Interestingly, COPI vesicles formation could not occur unless p23 
tail peptide was used, regardless of the liposomal lipid composition. Although 
the lipid composition might be important for the efficiency of budding (De 
Camilli et al., 1996; Roth and Sternweis, 1997), it does not seem to be one of 
the minimal requirements for budding to take place. 
 
2.4 SNAREs in the in vitro budding assay  
 
Coatomer, ARF1 and p24 family proteins are the minimal machinery needed 
to generate COPI coated vesicles as shown previously by usage of liposomes 
and purified proteins. 
It was shown that SNARE proteins are required for targeting and fusion. In 
fact, they form the minimal machinery for fusion and allow, in a very specific 
manner, the fusion of v-SNAREs containing vesicles to t-SNAREs containing 
target membranes (McNew et al., 2000; Nickel et al., 1999; Sollner et al., 
1993; Weber et al., 1998).   
To further investigate the mechanisms that lead to a complete cycle of COPI 
transport, including the disassembly of the coat and the fusion of COPI 
vesicles to a target membrane, tools need to be provided to link the machinery 
for budding to the machinery for fusion. That was the purpose of the present 
work. 
Full length yeast SNAREs as well as their cytoplasmic domains were 
produced as fusion proteins and reconstituted in p23 containing liposomes. It 
was suggested that coat assembly can direct v-SNARE incorporation into 
COPII vesicles (Matsuoka et al., 1998). Because SNAREs might have a role 
in segregation of distinct COPI vesicle populations, their incorporation into 
COPI vesicles was addressed using the in vitro budding assay.  
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Endogenous yeast coatomer was produced as well as recombinant ARF1. An 
active recombinant ARF-GTPase activating protein (ARF-GAP) was produced 
and attempts to restore its biological activity were successful. 
A large part of the present work was dedicated to generate large liposomes 
since the presence of small liposomes turned out to be a limiting step in the in 
vitro budding assay. As coated small liposomes float at the same density as 
bona fide COPI vesicles, they were indistinguishable from newly generated 
COPI coated vesicles. Attempts to select for large size liposomes were 
successful. 
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1 Cloning, expression and purification of proteins 
  
1.1 GST-fusion SNAREs 
 
 SNARE proteins are key players in the fusion of vesicles in the cell. They 
are class II transmembrane proteins that consist of a coiled coil domain at the N-
terminus in addition to one membrane span at the C-terminus. However Ykt6p 
does not share this topology and is anchored to the membrane via an isoprenyl 
residue (McNew et al., 1997). In addition, they are highly conserved among 
species.  
Although in vitro experiments have shown that COPI, COPII and clathrin coated 
vesicles can form from liposomes without addition of cargo proteins and transport 
factors (Bremser et al., 1999; Matsuoka et al., 1998; Spang and Schekman, 
1998), these factors need to be packaged in vivo into COPI vesicles thus 
allowing efficient transport. SNARE proteins represent a prominent class of 
transport factors that are essential in consumption of vesicles.  
To address the question how SNAREs are packaged into COPI vesicles during 
budding, they were produced to be reconstituted into synthetic liposomes. As 
they are exposed to the cytosolic face of a membrane compartment, they are 
likely to interact with cytosolic factors ARF1 and coatomer (Rein et al., 2002; 
Spang and Schekman, 1998) or with the cytoplasmic tail of the transmembrane 
p24 family members, all involved in budding of COPI vesicles. Six yeast SNARE 
proteins were chosen, namely Bos1p, an ER protein that recycles between Golgi 
and ER in a COPI dependant manner (Ossipov et al., 1999), Gos1p (McNew et 
al., 1998) a SNARE involved in intra Golgi transport, Sec22p which is associated 
with the pre Golgi intermediate compartment (Zhang et al., 1999); (Ballensiefen 
et al., 1998), Bet1p an early Golgi SNARE (Ossipov et al., 1999), Vti1p implicated 
in Golgi retrograde traffic (Lupashin et al., 1997) and Ykt6p . They are all present 
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in the ER and Golgi and participate in the process of fusion of COPII and COPI 
vesicles, respectively.  
Two cloning strategies were developed; the first was to clone the full length 
proteins while the second consists of cloning their cytoplasmic domain to which a 
cysteine was added (Fig.1). In this case the cysteine will allow a chemical 
anchoring of the protein to a lipid moiety leading to its reconstitution into 
liposomes. This reaction allowed originally to synthesize lipopeptides by 
anchoring peptides to a lipid moiety (Bremser et al., 1999). In both cases the 
SNARE genes were fused to GST at the N-terminus and for this purpose cloned 
into PGEX-2T vector (Amersham biosciences). 
 
Figure 1: Cloning strategies of the yeast SNAREs. The first strategy shown in panel A consists 
in cloning Bos1p, Gos1p, Sec22p, Bet1p, Vti1p as full length proteins fused to GST. The second 
strategy (panel B) consists in cloning only the cytoplasmic domains of these fusion proteins to which 
a cysteine was added. GST was fused to the N-terminus. For Ykt6p, only the second version was 
possible since no transmembrane domain is present in this protein. 
 
SNARE proteins were produced in BL21 (DE3)-pLys E. coli. The cultures were 
grown until an OD600 = 0.5 and their expression were induced with 0.1 mM IPTG. 
As the proteins were fused to GST, they were purified by affinity chromatography 
on Glutathion-Sepharose beads (Amersham biosciences). Fig. 2 shows the 
purification of various SNAREs. Panels A, B, C, D show the purification of full 
length Gos1p, Bet1p, Vti1p and sec22p as well as their cytoplasmic domains. 
Panel D shows the purification of Ykt6 to which a cysteine was added at the C-
terminus and the cytoplasmic domain of Bos1p. 
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Figure 2: SDS-PAGE analysis of affinity purified of GST-SNAREs (Gos1p, Bet1p, Vti1p, 
Sec22p, Ykt6p and Bos1p on Glutathion-sepharose beads. BL21(DE3) p-Lys E. coli bacteria 
were transformed with pGEX-2T plasmids carrying Ampiciline resistance in which different 
SNARE genes were cloned under the control of T7 promoter. Cells were grown in LB medium 
(typically 1 liter) at 37°C until OD=0.5-0.6 and expression was induced with IPTG at a 
concentration of 0.1 mM for 3 hours at 37°C. Cells were pelleted and resuspended in PBS buffer, 
pH=7.3 containing protease inhibitor tablets (Roche) and broken using a cell disrupter (Avestin 
EmulsiFlex-C5) at a pressure of 10000 to 15000 psi. The homogenates are ultra centrifuged at 
100,000g for 60 minutes. The resulting supernatant is incubated with Glutathione-Sepharose 
beads (previously washed with PBS in the case of SNARE cytoplasmic domains or with PBS 
supplemented with 1% (w/v) n-Octyl-β-D-glucopyranoside (OG) in the case of full length proteins) 
for 1 hour at 4°C to allow binding of GST to the Glutathione-Sepharose beads. This mixture is 
loaded onto disposable columns (Bio-Rad) with a frit so that the beads to which GST-SNAREs 
have bound are retained. After extensive washing with PBS (in the case of cytoplasmic domains) 
and PBS+OG (in the case of full length proteins), the bound protein is eluted with 20 mM 
Glutathion in Tris-HCl at pH = 8. Proteins were loaded on 15 % SDS-PAGE and stained with 
Coomassie blue. 
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1.2 The p24 family members 
 
The p24 family members are class I conserved transmembrane proteins 
that cycle in the secretory pathway. They are regarded as putative cargo 
receptors (Schimmoller et al., 1995; Sohn et al., 1996; Stamnes et al., 1995) that 
are necessary for vesicular transport (Schimmoller et al., 1995). In fact, p24 
family members were shown to interact with coatomer (Dominguez et al., 1998; 
Sohn et al., 1996) and with ARF1 (Gommel et al., 2001) via their cytoplasmic tail.  
Past attempts to produce these proteins in a native form resulted in total 
insolubility even in presence of detergent. Therefore to increase their solubility, 
the signal peptide was removed and the proteins were tagged with thioredoxin 
and purified in presence of 1% (w/v) OG. Pure proteins are then obtained (Fig. 
3). The p23 human cDNA was cloned with a thioredoxin-tag, a 6XHis-tag and an 
S-tag placed under the control of T7 promoter in pET-32 Xa/LIC plasmid. Origami 
(DE3) E. coli were transformed with the constructed plasmid, grown in LB 
medium until OD600 = 0.6 and expression was induced by addition of 0.1 mM 
IPTG. The protein was purified over a Nickel-Agarose column (Fig. 3), analyzed 
by SDS-PAGE and stained with Coomassie. 
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Figure 3: SDS-PAGE analysis of 
affinity purified human p23. 
Panel A shows the construct that 
serves to express human p23 in 
bacteria. It was tagged with 
Thioredoxin, a 6XHis tag and an 
S-tag. Purification was achieved 
by affinity chromatography (panel 
B);  After binding to the Nickel-
Agarose column, and extensive 
washing, the full length p23 
protein tagged to thioredoxin and 
6Histidine was eluted in 250 mM 
Imidazole containing 1% (w/v) OG 
at pH 8. Proteins were loaded on 
an SDS-PAGE and stained with 
Coomassie blue.
 
1.3 Native yeast ARF1p and human ARF1  
 
 ADP-ribosylation factor1 (ARF1) is a member of the Ras GTPase 
superfamily. These proteins are critical in different vesicular transport pathways 
in eukaryotic cells. As with other members of the Ras superfamily, ARF1 is 
present in the cell in two different nucleotide states, a cytosolic inactive form 
(ARF1-GDP) and a membrane bound active form (ARF1-GTP). It is recruited to 
the membrane in its GDP form by p23 tail peptide (Gommel et al., 2001) and is 
anchored to the membrane upon exchange of GDP to GTP. This very slow 
reaction (Franco et al., 1998; Frank et al., 1998; Goldberg, 1998; Mossessova et 
al., 1998; Peyroche et al., 1996; Togawa et al., 1999) is markedly accelerated by 
the action of nucleotide exchange factors (GEFs). To be released from the 
membranes and thus be available for other rounds of action, ARF-GTP has to be 
converted back to ARF-GDP, a reaction that is accelerated by GTPase activating 
proteins (GAPs) (Cukierman et al., 1995; Goldberg, 1998; Makler et al., 1995).  
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In the context of budding vesicles from membranes, ARF1 is a key protein since 
it has been shown to be one of the minimal requirements for this process to 
occur (Bremser et al., 1999). 
1.3.1 Yeast ARF1p 
 
 ARF1p is subject to a major co-translational modification that insures its 
membrane targeting, the addition of myristic acid (C14:0) at its N-terminus. 
Myristoylation is catalyzed by NMT1 (N-myristoyl-transferase1) (Towler et al., 
1987), an enzyme that links specifically the C14 saturated fatty acid to the first 
glycine residue at the N-terminus of ARF1p via an amide bound (Olson et al., 
1985). This reaction occurs cotranslationally to the production of ARF1p (Olson 
and Spizz, 1986; Wilcox et al., 1987) and is preceded by the action of another 
enzyme, Methionine amino peptidase that removes the starting methionine at the 
N-terminus of ARF1p leaving the glycine residue accessible to NMT1.  
The ARF1 and NMT1 genes were amplified from yeast genomic DNA by PCR.  
To obtain myristoylated ARF1p, a co-expression of both ARF1p gene and the N-
myristoyl transferase 1 (NMT1) was necessary. The ARF1p gene was then 
cloned in pET24a vector (Novagen) while NMT1 was cloned in pACYC DUET1 
(Novagen) vector. The two vectors carry two different antibiotic resistances 
(Kanamycine and Chloramphenicol, respectively) and have different origins of 
replication, so that they do not compete for the machinery of replication. BL21 
(DE3) STAR E. coli cells (Invitrogen) were co-transformed with the two plasmids. 
These cells contain a chromosomal copy of the gene encoding the RNA 
polymerase from the T7 phage which is placed under the control of the lac 
repressor. Addition of IPTG allows the expression of the T7 polymerase (by 
derepressing the lac repressor) that acts on the T7 promoter to express the 
cloned gene. Practically, cells were grown in 1 liter LB medium until an OD600= 
0.2 to 0.4 before addition of myristic acid. When an OD600 of 0.6 was reached, 
cells were induced with 1mM IPTG at 27°C for 3 hours. At this temperature, the 
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myristoylation is increased due to the fact that methionine aminopeptidase 
becomes rate limiting(Franco et al., 1995). 
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Figure 4: Co-expression of ARF1p-Pet24 
and NMT1-pACYC-DUET1 in BL21 
(DE3) STAR bacteria. The two plasmids 
carry respectively Kanamycine and 
Chloramphenicol resistances. After 
induction with 1mM IPTG at 27°C for 3 
Hours (I), only small amounts of NMT1 are 
produced whereas ARF1p is highly over 
expressed and represents around 50% of 
total protein. The promoter is tight since no 
expression is observed in the uninduced 
bacteria (UI).  
 
The bacterial pellet was resuspended in MES buffer (25 mM MES, 1mM DTT, 5µM 
GDP, 1mM MgCl2, pH=5.7). The post lysate supernatant was precipitated with 
ammonium sulfate at 35% saturation. Myristoylated ARF1p precipitates while its 
non-myristoylated counterpart remains soluble. Ammonium sulfate was removed 
by gel filtration and ARF1p was purified by cation exchange chromatography over 
a Source-S column.  
Typically myristoylated ARF1p elutes between 17% and 25% buffer B 
corresponding to 85 mM to 125 mM NaCl. Apparent homogeneity after one column 
step is observed in fractions 19 and 20 yielding 3.5 to 4 mg pure myristoylated 
ARF1p (Fig.5) 
A high degree of myristoylation is necessary for the biological activity of ARF1p on 
membranes. For comparison, non-myristoylated ARF1p was also produced as a 
negative control.  
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Figure 5: Purification of myristoylated ARF1p by cation exchange chromatography. The 
column was equilibrated with buffer A followed with buffer B to provide the exchange group with 
the counter ion Na+, then with additional 2 column volumes of buffer A. After Ammonium sulfate 
precipitation (35% saturation), the sample was desalted using PD10 column to remove any trace 
of salts and loaded onto the Source-S column. Most of the proteins flow through at this pH. 
Submitted to a NaCl gradient after binding to the SOURCE-S material, myristoylated ARF1p 
eluted between 17% and 25% buffer B corresponding to 85 mM to 125 mM NaCl. 5µl of each 
fraction (from 17 to 26) were loaded on a 15% SDS-PAGE that was stained with Coomasie blue. 
 
To produce non-myristoylated ARF1p, neither myristic acid nor NMT were present 
during its expression. After lysing the cells, the soluble fraction was precipitated 
with 50% Ammonium Sulfate saturation to make sure ARF1p will not remain 
soluble, since at 35% saturation, non-myristoylated ARF1 remains soluble. The 
purification was carried out as described for myristoylated ARF1p and after 
Source-S column, 3 mg of pure ARF1p were obtained in fractions 24, 25 and 26 
(Fig. 7). 
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On the other hand, the question whether providing appreciable amounts of NMT 
would increase the degree of myristoylation of ARF1p and therefore its biological 
activity was addressed by co-expressing the two proteins after cloning  their 
respective genes into a bicistronic vector (Fig. 6). As compared to the system 
described above (Fig.4), this allowed the production of significant amounts of 
NMT1 (Fig. 6). 
 
 
 
Figure 6: Co-expression of NMT1 and ARF1p in E. coli using a bicistronic vector and 
purification of myristoylated ARF1p by cation exchange chromatography. In order to 
overcome the low level of expression of NMT1 when co transformed with vector carrying the ARF1p 
gene (See Fig. 4), these two genes were cloned in a bicistronic vector pACYC-DUET1 that carries 
chloramphenicol resistance. NMT1 gene was cloned in the first multiple cloning site (MCS) while 
ARF1 was cloned in the second. Both MCS are under the control of a T7 promoter. (A) High 
expression levels were obtained for NMT1 and ARF1p after 3 hours induction with 1mM IPTG (I) as 
compared to the uninduced sample (UI). (B) Elution profile of ARF1p from Source-S column. A 
NaCl gradient (from 0% to 20% buffer B, then from 20% to 50% and finally from 50% to 100% buffer 
B) was applied under a flow rate of 5 ml/min. ARF1p eluted between 24% and 28% buffer B 
corresponding to 120 mM to 140 mM NaCl. A volume of 5µl of each fraction (from 22 to30) was 
loaded on a 15% SDS-PAGE and stained with Coomasie blue. 
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Usage of the bicistronic vector yielded a recombinant ARF1p that has the same 
characteristics as the one produced by double transformation. They have a 
similar behavior on SDS-PAGE (Fig. 8) and they exchange nucleotide with 
similar efficiencies. However, as the bicistronic vector is a very low copy vector, 
the total amount produced in 1 liter is smaller. These data suggest the double 
expression system is better. 
 
 
 
Figure 7: Elution Profile from a SOURCE-S cation exchange column of non-myristoylated 
ARF1p over expressed in bacteria. The column was equilibrated with buffer A then with buffer 
B to provide the exchange group with the counter ion Na+, in addition the column was equilibrated 
back with buffer A before loading the sample. After Ammonium sulfate precipitation (50% 
saturation), the sample was desalted using PD10 column to remove any trace of salts and loaded 
onto the column. Most of the proteins flew through at this pH. Submitted to a NaCl gradient after 
binding to the SOURCE-S material, non-myristoylated ARF1p eluted between 35% and 42.5% 
buffer B corresponding to 175 mM to 212.5 mM NaCl. A volume of 5µl of each fraction (from 21 to 
31) was loaded on a 15% SDS-PAGE and stained with Coomassie blue. 
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To determine that ARF1p is myristoylated, and taking advantage of its property to 
run slightly faster than its non myristoylated counterpart on SDS-PAGE as shown 
by Franco and colleagues for the recombinant bovine ARF1 (Franco et al., 1996), 
migration of the two proteins was compared on SDS-PAGE (Fig. 8). Indeed, two 
forms appear that migrate differently.  
 
 
Figure 8: myristoylated ARF1p 
runs faster on an SDS-PAGE 
compared to the non-
myristoylated one. Lane1: 
myristoylated ARF1p produced in a 
bicistronic vector together with NMT 
(fraction 26, Fig. 6). Lane 2: 
myristoylated ARF1p from fraction 
20 (Fig. 5). Lane3: non-
myristoylated ARF1p from fraction 
25 (Fig. 7). Lane 4: myristoylated 
and non-myristoylated ARF1p 
(loaded in lanes 2 and 3). Proteins 
were loaded on a 15% SDS-PAGE. 
The myristoylated ARF1p runs 
slightly faster compared to its non-
myristoylated counterpart on an 
SDS-PAGE. 
 
1.3.2 Human ARF1 
 
 A protocol by Franco and colleagues (Franco et al., 1996) allows purification 
of myristoylated human ARF1. It consists of an Ammonium Sulfate precipitation 
followed by a DEAE column (weak anion exchanger) and a Mono-S column (strong 
cation exchanger). Herein, a method was established so that only a cation 
exchange step was used after Ammonium Sulfate precipitation. The same 
procedure as for yeast ARF1p allows purification to apparent homogeneity of 
human ARF1p (Fig. 8). Despite the identity between Human and yeast ARF1 
(77%), the level of myristoylation of human ARF1 is far lower compared to its yeast 
homologue. This could be explained by the fact that ARF1p is a natural substrate 
for NMT1 (both yeast proteins), while the human ARF is not, and therefore the 
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reaction is less efficient. Ideally human ARF1 is myristoylated up to 20% as 
indicated in Fig. 9  
 
Figure 9: Over expression and purification of human ARF1 expressed in E. coli by cation 
exchange chromatography. (A) Expression of human ARF1 cloned into pet11-d (Novagen) and 
NMT cloned into pBB131 (Duronio et al., 1990) in E. coli BL21(DE3). The two vectors have 
Ampiciline and Kanamycine resistances respectively and the cloned genes are placed under the 
control of T7 and tac promoters respectively. Human ARF1 and yeast NMT1 are expressed after 
induction with 1 mM IPTG (I) as compared with the uninduced bacteria (UI). Typically about 20% 
human ARF1 migrates faster on SDS-PAGE, representing the myristoylated form. (B) After 
precipitation at 35 % Ammonium Sulfate saturation, the precipitate was resuspended in buffer A 
and desalted. Purification was achieved using a Source-S column as described for the yeast 
ARF1p. Myristoylated human ARF1 eluted between 17 and 20% buffer B corresponding to 85 to 
100 mM NaCl. A volume of 5µl per fraction were loaded on a 15% SDS-PAGE and stained with 
Coomassie blue. 
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1.4 Expression, purification and refolding of Glo3p, an ARF 
 GTPase activating protein (GAP) in E. coli 
 
 ARF-GTPase activating proteins (GAPs) are key regulators of ARFs. One of 
their major characteristics is the Zinc finger domain which is responsible for 
GTPase activation. Glo3p seems to be specific for retrograde transport from Golgi 
to ER in yeast. However its function can be complemented by another yeast GAP, 
Gcs1p in vivo. In addition to their GTPase activation role on ARF1, ARF GAPs 
were proposed to sort cargo into COPI vesicles since they might interact with the 
KDEL receptor ERD2 and p24 family proteins (Aoe et al., 1999); (Lanoix et al., 
2001). Glo3p is therefore an interesting regulatory element for ARF1p in the 
context of budding of COPI vesicles using purified proteins and liposomes. 
Glo3p was cloned into pET 15-a with a 6XHistidine Tag and was purified according 
to Poon and colleagues (Poon et al., 1996). Bl21(DE3) STAR E. coli were 
transformed with pET15a-GLO3 plasmid and grown at 37°C in LB medium 
supplemented with 100µM ZnCl2 until OD600 = 0.5-0.6 and expression was induced 
with 1 mM IPTG for 3 hours. After harvesting the cells and breaking them, the post-
lysate supernatant does not contain any Glo3p-His since the protein is completely 
insoluble. Decreasing the temperature with induction down to 16°C did not 
increase solubility. The post-lysate pellet was resuspended in 8 M urea and 
pelleted again and Glo3p-His was purified from the soluble fraction by affinity 
chromatography over Nickel-Agarose beads (Novagen) and eluted with 250 mM 
Imidazole in presence of 8 M urea (Fig. 10, panel A). The protein concentration is 
adjusted to 0.1mg/ml and the buffer is exchanged to Hepes buffer (25 mM Hepes, 
150 mM KOAc, 1mMDTT, 100 µM ZnCl2, 20% glycerol, pH 7.2) by the usage of 
PD10 column (Amersham biosciences). Each passage through this column 
removed 95% of urea, therefore after two passages the urea concentration 
dropped from 8M to 20 mM, a concentration in which the protein is no longer 
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denatured (Fig. 9, panel B). Renatured Glo3p-His recovers its GTPase activating 
function on ARF1p as described later in chapter 3. 
 
Figure 10: Purification under denaturing conditions and refolding of Glo3p-His. (A) Three 
consecutive elutions of denatured Glo3p-His from Nickel-Agarose beads with 250 mM Imidazole 
In presence of 8M Urea;  (B) Glo3p-6HIS was refolded by rapid buffer exchange in PD10 columns 
and after adjusting the concentration to 0.1 mg/ml. Gels were stained with Coomassie blue.  
1.5 TAP-Tagged native yeast coatomer complex 
 
 Endogenous coatomer from yeast can be purified to homogeneity using the 
tandem affinity purification (TAP-Tag) technique (Rigaut et al., 1999). The protein 
of interest, in this case δ-cop, is tagged with a Calmodulin binding domain followed 
by a TEV protease cleavage site followed by protein A (Cellzome). A first affinity 
column consisting of IgG beads allowed the binding of protein-A tag. The protein is 
released from the IgG beads by TEV protease cleavage. A second affinity column 
consisting of Calmodulin coupled beads allowed the binding of the protein via the 
Calmodulin binding domain in presence of Ca2+. Elution of native endogenous 
protein with its interacting partners (the other coatomer subunits in this case) is 
then achieved by addition of EGTA. 
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The last step in purifying yeast coatomer complex TAP-tagged at the δ-cop (Ret2p) 
subunit is a gel filtration step using Superose-6 (Amersham biosciences). 
Aggregates were present in the exclusion volume (typically 30% of the bed volume 
corresponding to 0.8 ml) and coatomer elutes between 1.1 ml and 1.5 ml. Based 
on the calibration of the column, coatomer complex has an apparent molecular 
weigh of 750 KD while the predicted size assuming a one to one stoichiometry 
between the seven subunits is 560 KD.  
 
Figure 11: TAP-tag purification of yeast δ-cop-TAP coatomer.  Lanes 1 and 2 in panel B show 
the eluates from the IgG and the Calmodulin affinity columns respectively. Coatomer was further 
purified using a Gel filtration column (Superpose 6: PC 3.2/30, 2.4 ml bed Volume). Rest of the 
panel B shows the elution profile of caotomer. The column was previously calibrated (A right) with 4 
standard proteins (Thyroglobulin, 660 KD; Alcohol dehydrogenase 150 KD; Ovalbumin, 45 KD; 
Lysosyme, 14.5 KD).  The running buffer contains 25 mM Hepes at pH= 7.4, 200 mM NaCl, 1 mM 
DTT, 5% Glycerol, 0.02% Sodium Azide. A volume of 10 µl of each fraction was loaded on 10% 
SDS-PAGE and silver stained (Silver Quest, Invitrogen). 
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1.6 Native coatomer complex from rabbit liver 
 
 Mammalian coatomer, a seven subunit complex, was first purified in its 
native state from rabbit liver cytosol (Pavel et al., 1998; Serafini et al., 1991). After 
Ammonium sulfate precipitation, a DEAE-Sepharose and two consecutive 
Resource Q columns were used. Typically, from 15 to 20 g of cytosolic protein, 20 
to 30 mg coatomer can be obtained to an apparent purity of 50 to 60 %, as shown 
in Fig. 12 
 
 
 
Figure 12: Purified rabbit liver coatomer. Coatomer 
was purified from 15 to 20 g cytosolic proteins in three 
steps. After Ammonium sulfate precipitation, three 
columns wetre used, A DEAE Sepharose and two 
Resource Q columns. 50% to 60% pure coatomer 
elutes was obtained. Here is shown a Coomassie 
stained 10% precast gel (Invitrogen). Details are 
provided in the methods section. 
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2 Setting up a reconstituted system with chemically 
 defined components 
2.1 Liposomes stand for Golgi membranes 
 
2.1.1 Generating large liposomes 
 
 Reconstitution of COPI vesicular transport in vitro requires purified 
components. In addition to the proteins described in chapter 1, here we address 
the membrane environment that mimics Golgi membranes and from which COPI 
vesicles emerge. Analysis of Golgi membranes in mammalian cells (van Meer, 
1998)) (Brugger et al., 1997) allowed determining their lipid composition as 
summarized in table1. As generating large liposomes has been achieved mainly 
with a modified method from Kinuta and colleagues (Kinuta and Takei, 2002; 
Kinuta et al., 2002), this method was applied. 
To generate Golgi like liposomes, a lipid mixture (referred to as Golgi mix) was 
dried under Argon to remove solvent. The lipid film obtained was hydrated with a 
water saturated Argon stream before being finally resuspended in an aqueous 
buffer (Hepes 25 mM pH = 7.4, KCl 150 mM, Sucrose 2.5% (w/v)). The mixture 
was submitted to 10 cycles freeze (liquid nitrogen) and thawing (50°C) and kept in 
a water bath at 37°C for 2 hours. Liposomes that form at this step were finally 
selected for size by extrusion through 800 nm pore size filters (Avestin).  
 
 
 
Table 1: Mammalian Golgi lipid 
composition used to prepare liposomes 
(Golgi mix). PC, phosphatidylcholine. PE, 
phosphatidylethanolamine. PS, 
phosphatidylserine. PI, phosphatidylinositol. 
SM, sphyngomyeline. CL, cholesterol. 
Rhodamine-PE (Rhodamine coupled to 
phosphatidylethanolamine is used here to 
serve as a fluorescent tracer for liposomes. 
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Liposomes were checked by electron microscopy and their size was found still not 
to be homogenous, although a large part of the liposomes have a diameter of 200 
nm (Fig. 13). Bigger structures coexist with small ones. In the context of budding 
COPI vesicles (~70 nm diameter) from donor liposomes it is critical to make sure 
the liposomes size is large and that no small preexisting structures would be 
present, in order to avoid small coated vesicles to be generated by mere coating 
rather than by coating and budding.  
In order to further purify a fraction of large liposomes, gel filtration was applied.  
 
Figure 13: Analysis of liposomes by electron microscopy. Two Electron microscopy 
photographs representing the same preparation of unilamellar liposomes obtained under the 
conditions described above. Picture A shows a broad size distribution of liposomes ranging from 
less than 100 nm to 400 nm diameter sizes. Picture B shows the presence of very large structures 
(diameter above 500 nm). 
 
A Sephacryl-1000 column (Amersham biosciences) that allows exclusion of 
particles with a diameter over 400 nm (corresponding to 30% of the bed volume, 
according to the manufacturer specifications) was equilibrated with 3 bed volumes 
of a Hepes buffer (Hepes-KOH 25 mM, KCl, 150 mM, pH=7.4) supplemented with 
20 mg/ml BSA to prevent liposomes from unspecific interactions with the column. 
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The liposomes contained 1 mol% of Rhodamine-PE, a fluorophore that is excited 
at λex=558 nm and emits at λem=592 nm. This way, liposomes are detected by their 
fluorescence (Fig. 14). The size of liposomes can be directly assessed by Dynamic 
light scattering (DLS).  
 
 
Figure 14: Size separation of liposomes by Gel filtration. 
Liposomes were loaded onto a 55 ml Sephacryl-1000 column and 
eluted at a flow rate of 1 ml/min in Hepes buffer (25 mM Hepes, 
150 mM KCl, pH 7.4). 
Column was previously 
equilibrated in 3 bed 
volumes of the same buffer 
supplemented with 20 
mg/ml BSA. Since 
liposomes contain 
Rhodamine-PE, a 
fluorophore that emits at 
λem=592 when excited at 
λex=558 nm, they were 
monitored via the 
fluorescence intensity of the 
fluorophore. Liposomes 
were eluted from the 
column starting from 22 ml. 
Fluorescence was 
measured from fractions 10 
to 107.  
 
 
Directly after gel filtration, the size of liposomes was checked by dynamic light 
scattering. As expected, the first liposomes to be eluted from the column had the 
largest size (Fig. 14).  
 
 
Figure 15: Size distribution of the 
liposomes after gel filtration 
measured by dynamic light 
scattering (DLS). Fractions from 22 
to 36 were submitted to DLS 
measurements and their diameter was 
calculated using an algorithm 
integrated in the software from the 
supplier (see details in Materials and 
methods). 
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Since the liposomes were made in a buffer containing 2.5% sucrose, a way to 
concentrate them after separation by size was to pellet the fractions containing the 
largest liposomes by centrifugation at 900g. They appeared as a red pellet that 
could be resuspended in a desired volume of buffer. Fractions 22 to 27 were 
pelleted and their lipid content calculated (see quantification principle in 2.1.3). The 
lipid content in this case represented 9% of the starting liposomes loaded onto the 
column. The recovery of large liposomes by gel filtration was usually around 10% 
of the input. 
 
2.1.2 Synthesis of lipopeptides with cytoplasmic domains of the p24 
 family members 
 
 As a next step to generate the components needed for the formation of 
budding competent liposomes from chemically defined building blocks, lipopeptides 
were prepared that contain the cytoplasmic domains of p24 family members 
proteins. By this way, these coatomer receptor domains can be stably incorporated 
into liposomes. 
The C-terminal cytoplasmic domain of p24 family members can be synthesized 
and covalently attached to a lipid moiety (Nickel and Wieland, 2001). A 
commercially available lipid (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n-[4-
(p-maleimidophenyl) butyramide] (MPB-PE; Avanti Polar lipids) was used. MPB-PE 
contains a maleimido group which reacts with the thiol group of cysteine added to 
the peptide to form a stable thioether bound (Fig. 15). Lipopeptide was then 
purified by reverse phase chromatography on a Sep-Pak C18 cartridge. 
Typically the yield of this reaction (based on the input of MPB-PE) was above 60% 
for p23 and less than 10% for p24 lipopeptides. 
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Figure 16: Synthesis of p23 lipopeptide. p23 tail peptide carrying an additional cysteine at the N-
terminus was chemically anchored to a lipid moiety (MPB-PE) to form a lipopeptide. The maleimido 
group of MPB-PE reacted with the free thiol group of the cysteine to form a stable thioether bound. 
 
The sample was loaded onto a reverse phase chromatography cartridge (Sep-Pak 
C18) and subjected to an Acetonitrile step gradient in the presence of 0.1% 
trifluoroacetic acid (TFA) (Nickel and Wieland, 2001). p23 lipopeptide eluted at 
80% and 90% Acetonitrile / 0.1% TFA while p24 lipopeptide elutes at 90% and 
100% Acetonitrile (Fig. 17) 
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Figure 17: Analysis of p23 and p24 lipopeptides synthesis by thin layer chromatography 
(TLC). Panel A shows p23 lipopeptide eluted from the Sep-Pak C18 column at 80% and 90% 
Acetonitrile + 0.1% TFA. MPB-PE and p23 tail peptide were also loaded as controls (CT1 and CT2 
respectively) on the TLC and showed a different running behavior compared to p23 lipopeptide. 
Panel B showes that p24 lipopeptide eluted at 90% and 100% Acetonitrile + 0.1% TFA. The running 
solvent was a mixture of butanol, pyridine, acetic acid (glacial) and water (9.7: 7.5: 1.5: 6; v:v:v:v). 
After being developed, silica plates were dried and placed in a chamber containing solid iodine that 
allowed staining MPB-PE, p23 and p24 peptides and lipopeptides. 
 
 
2.1.3 Quality control and quantification of liposomes 
 
 The quality of liposomes is an important criterion for using them as a 
membrane matrix to study vesicular transport mechanisms in vitro. Under the 
conditions described earlier (paragraph 2.1.1.), liposomes appear to be unilamellar 
(Fig. 13). Size exclusion chromatography allows selecting for the largest structures. 
The sizes of liposomes measured by DLS were in accordance with the sizes given 
by electron microscopy, providing an easy and fast method to check the size of 
liposomes routinely. 
Results 
 
 
 
 
37
On the other hand, to quantify the lipid content in a sample containing liposomes, a 
classical method allows determination of their phosphate content (Rouser et al., 
1970) that correlates to the lipid content. When Golgi like lipids (Golgi mix) were 
used, cholesterol (16%) is subtracted since it is not a phospholipid. 
Alternatively and in order to increase the sensitivity of the detection of liposomes 
and to allow a much faster analysis, profit was made of a fluorescent lipid tracer 
(Rhodamine-PE) to quantify lipids. 
 
 
Figure 18: Quantification of lipids using phosphate determination and Fluorescence. A shows 
a standard curve of known amounts of phosphate. B shows the amounts of phospholipids present 
in various volumes of the liposome preparation as deduced from A. C shows the fluorescence 
emitted from the same volumes of liposomes analyzed in B. three samples were checked for 
reproducibility. Liposomes were made under conditions described above so that 1mol% 
Rhodamine-PE was present. The fluorophore was excited at λex=558 nm and emission was 
analyzed at λem=592. 
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After standardization (Fig 18, A), the phospholipid amounts present in liposomes 
were deduced (Fig. 18, B) and correlated to the fluorescence intensities (Fig. 18, 
C). It was then possible to directly determine the amounts of phospholipids by 
monitoring the fluorescence of Rhodamine-PE. This was particularly useful to 
determine the amount of liposomes present after reconstitution. 
 
2.2 Reconstitution of SNARE proteins into liposomes 
 
 To study the incorporation of SNAREs into COPI coated vesicles in vitro, a 
major requirement was to include them into liposomes. This was achieved by two 
different methods. The first consisted of reconstituting the full length SNARE while 
the second made profit of the strategy described in Fig. 15 to chemically anchor 
cytoplasmic domains of SNAREs with an additional cysteine to MPB-PE. 
 
2.2.1 Reconstitution by dilution below the critical micellar   
 concentration 
 
 This method consisted of mixing the SNARE protein which was purified in 
presence of detergent (1% (w/v)) OG to a lipid film followed by a rapid dilution of 
the detergent (OG) below its critical micellar concentration (CMC) promoting 
liposomes formation (Weber et al., 1998) as shown in Fig. 19. 
Liposomes were recovered and concentrated by flotation in a Nycodenz gradient 
that consisted of 3 steps, 40%, 30% and 0% Nycodenz. The SNARE containing 
liposomes floated at the interface between 30% and 0% Nycodenz (Fig. 20), while 
uncoupled protein was found at the bottom of the gradient (40% Nycodenz). Since 
the liposomes contained 1 mol% Rhodamine-PE, they formed a visible red layer 
that was easily collected for analysis. 
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Figure 19: Preparation of full length SNARE containing donor liposomes. The micelle surrounding the 
transmembrane domain of the SNARE is disrupted after dilution, and the protein reconstitutes into 
liposomes. Detergent is then removed by dialysis. 
 
 
 
Figure 20: Reconstitution of GST-Sec22p-FL and GST-Vti1p-FL into p23 containing 
liposomes by dilution and dialysis. Panel A, lane 1 shows control p23 containing liposomes 
formed using the same method without addition of protein and in the presence of 1% OG (w/v) 
instead, lane 2 shows the reconstitution of GST-Sec22p-FL. Panel B shows the reconstitution of 
GST-Vti1p-FL. Either p23 containing liposomes or p23 and SNARE containing ones were floated in 
a Nycodenz gradient and collected in the 30% / 0% Nycodenz interface. 10µl samples were loaded 
on 10% precast SDS-PAGE (Invitrogen) in A and 15% SDS-PAGE in B and stained with Coomassie 
blue. 
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2.2.2 Reconstitution by chemical coupling to a cysteine residue 
 
 The strategy described in Fig. 15 was used to couple liposomes containing 
MPB-PE to the cytoplasmic domain of Bos1p fused to GST (GST-Bos1p-cys), and 
containing a C-terminal additional cysteine to (Fig. 21). 
 
 
Figure 21: Chemical coupling of GST-
Bos1p-cys to liposomes containing MPB-
PE. Lane 1 shows original liposomes 
containing p23 lipopeptides. After coupling, 
liposomes were floated in a Nycodenz step 
gradient and collected at the interface 
between 30% and 0%. 10µl samples were 
loaded on a precast 10% SDS-PAGE 
(Invitrogen) and stained with Coomassie 
blue (lane 2). 
Recovery of liposomes after floatation was checked by measuring the fluorescence 
intensity after coupling and comparison to standard amounts (Fig. 17). The protein 
coupling is estimated from the intensity of the protein band after reconstitution. 
After flotation, liposomes represent 80% of the input, and 50% of the input protein 
is present in the liposome fraction, indicating the coupling of 50% of the protein to 
MPB-PE containing liposomes. Given an average diameter of 200 nm, 65 Å2 per 
phospholipid, and a total amount of 40 µg of GST-Bos1-CD that was recovered, 
each liposome contains 7000 copies of SNAREs for about 2,000,000 phospholipids 
(1 SNARE for 270 phospholipids). 
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2.2.3 Orientation of SNAREs after reconstitution 
 
 The SNAREs reconstituted by dilution and dialysis (Fig. 19) can be oriented 
either to the lumen of the liposome or to the external part. Since the SNAREs fused 
to GST contain a thrombin cleavage site, an outside orientation would leave the 
cleavage site accessible. Interestingly, as shown in Fig. 22, Sec22p is completely 
digested indicating a total outside orientation, while a majority of Vti1p is digested 
(up to 80% based on the bands intensities), indicating Vti1p is predominantly 
oriented to the outside. Reconstitution by dilution and dialysis of SNAREs leads to 
an orientation that resembles their orientation in vivo. 
 
 
 
Figure 22: Orientation of SNAREs reconstituted in liposomes. After reconstitution, GST-Sec22-
Fl liposomes (A) and GST-Vti1p-FL liposomes (B) were submitted to digestion with 1 unit of the 
thrombin protease (lanes 2 in A and B) and analyzed by SDS-PAGE and Coomassie blue staining. 
Digestion was complete in the case of Vti1p (B) and complete to about 80% for Sec22p (A). Lanes 
1 in A and B show the input proteins before digestions. 
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3 Functional aspects 
 
 As another prerequisite to reconstitute liposome budding, the small GTPase 
ARF1 was expressed as a recombinant protein and purified. 
 
3.1 Nucleotide exchange activity of ARF1 and GAP activity of 
 Glo3p 
 
 After purification (see materials and methods), the biological activity of 
ARF1p, that is its conformational change upon exchange of GDP to GTP was 
measured In vitro by monitoring in real time the correlated increase of ARF1p 
tryptophan fluorescence (Antonny et al., 1997; Kahn and Gilman, 1986). Here, the 
fluorescence of Trp 78 is monitored. This tryptophan residue is conserved in the 
switch II domain of G-proteins α subunits whose fluorescence increases upon GTP 
binding (Faurobert et al., 1993). Nucleotide exchange activities of myristoylated 
yeast ARF1p (fraction 19, Fig. 5 and fraction 26, Fig. 6) as well as yeast non 
myristoylated ARF1p (fraction 25, Fig.7) were measured (Fig. 23, 24, 25). 
Furthermore, the kinetics of GTPase activation by Glo3p was determined (Fig.23, 
D). For comparison, nucleotide exchange activity of myristoylated human Arf1 was 
checked (Fig. 26)  
Nucleotide exchange activities were obtained by fitting the curves to a single 
exponential model (Y = IF (X<X0, Plateau, Plateau + (1-e(-K * (X-Xo)))). That takes 
into account the speed of the fluorescence increase to the plateau, represented by 
a velocity constant (K (s-1)). The span of the curve is a direct function of ARF-GTP 
concentration. Knowing the amount of ARF-GDP, specific activities can be 
represented as: Specific activity = (Span * K) / [ARF-GDP], (proportional to 
mol.L-1.s-1.µg-1) 
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Figure 23: Nucleotide exchange activity of myristoylated yeast ARF1p and GTPase activation 
by yeast Glo3p are liposomes dependent. Conformational change of ARF1p upon nucleotide 
exchange was monitored by intrinsic tryptophan fluorescence (excitation = 297.5nm, emission = 
340 nm) at 37°C. (A) Three µl of myristoylated ARF1p-GDP (1.11µg) was injected in a fluorescence 
cuvette containing 530 µl buffer (25 mM Hepes, 150 mM KCl, 2 mM MgCl2) and 60 µl of 3mM Golgi 
like liposomes. At the indicated times, GTP (50 nmol), EDTA (2 mM) and MgCl2 (2mM) were added. 
Addition of EDTA did not promote exchange of GDP to GTP since the fluorescence signal stays flat. 
(B) ARF1p-GDP (1.11 µg) was added to a fluorescence cuvette containing 180 nmol 
phosphatidylcholine liposomes in the same buffer as in (A). At the indicated times, GTP (50 nmol), 
EDTA (2 mM) and the ARF-GAP Glo3p (1µg) were added. Addition of EDTA promoted GDP 
release and its substitution by GTP (increase of fluorescence). ARF1p GTPase activity was 
triggered by the addition of Glo3p. (C) Increase of fluorescence observed in (B) was fitted to an 
exponential model that determines the velocity constant (K) and the span between the plateau 
before addition of EDTA and the plateau at saturation. (D) After addition of 1µg Glo3p, decrease of 
fluorescence (hydrolysis of GTP from ARF1p by the action of Glo3p) is plotted according to an 
exponential regression decay model; the velocity constant (K) and the span were determined.  
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In order to determine the GTPase activation of Glo3p, the curve was fitted to a 
single exponential decay model. One µg of refolded Glo3p (Fig. 10) was added to 
the fluorescence cuvette after exchange had occurred (Fig. 23, B), and resulted in 
a decrease of fluorescence. Velocity constant (K) and span were measured and 
specific activities calculated (Specific activity = (Span * K) / [ARF-GDP], 
(proportional to mol.L-1.s-1.µg-1). 
The activities are summarized in Table 2. 
 
 
Figure 24: myristoylated yeast ARF1p produced using a bicistronic vector encoding 
AFR1p and NMT1 is comparable to the ARF1p produced by double transformation. 
Nucleotide exchange activity was measured under the same conditions described in Fig 21 
except that 1.4 µg of ARF1p were added. (A) No increase of fluorescence was observed in the 
absence of liposomes. (B) In presence of liposomes and upon addition of EDTA, increase of 
tryptophan fluorescence was observed and fitted to an exponential model. The velocity constant 
(K) and the span were determined.  
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Non myristoylated ARF1p (fraction 26, Fig. 7) was submitted to the same assay. 
Non myristoylated ARF1p was able to exchange GDP for GTP both in presence 
and in absence of liposomes (Fig. 25) 
The fact that none of the myristoylated ARF1p described above was able to 
exhibit a nucleotide exchange in solution (panels A) is, in addition to their mobility 
on SDS-PAGE (Fig. 8), an indication that they are totally myristoylated. 
Otherwise, one would expect to see a small increase of fluorescence in solution 
after addition of EDTA, which did not occur (Fig 23 and 24).  
 
 
Figure 25: Non myristoylated ARF1p exhibits a nucleotide exchange activity that is 
liposome independent. Nucleotide exchange activity was measured under the same conditions 
described in Fig. 23 and 24 except that 1.12 µg of ARF1p were added in this case. Upon addition 
of EDTA, increase of fluorescence was observed both in presence (A) and in the absence (B) of 
liposomes. The plateau and the span were fitted to an exponential model and velocity constants 
(K) were calculated. 
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The nucleotide exchange activity of human ARF1 was checked (Fig. 26) and 
compared to yeast ARF1p. Specific activity of the human ARF1 compared to the 
yeast ARF1p is lower by one order of magnitude. This might be due to the lesser 
degree of myristoylation of human ARF1 (Van Valkenburgh and Kahn, 2002). 
However, the non myristoylated yeast ARF1p shows a nucleotide exchange 
activity comparable to its myristoylated counterpart, indicating that myristoylation 
is necessary but not sufficient to achieve full nucleotide exchange activity. 
 
 
 
 
 
Figure 26: myristoylated human ARF1 nucleotide exchange activity. Myristoylated Human 
ARF1-GDP (1.78µg) was added to a fluorescence cuvette and its nucleotide exchange activity 
was measured under the conditions described for the yeast ARFs. Instead of GTP, one of its non 
hydrolysable analogues was used (GMP-PNP). A shows the crude measurement. The 
fluorescence increase was fitted to an exponential model B. 
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Table2: Specific activities of myristoylated yeast ARF1p, 
non myristoylated yeast ARF1p and human ARF1. 
Activities of the two species of myristoylated ARF1p, the non 
myristoylated counterpart as well 
as the myristoylated human 
ARF1p are compared. 
(*) Since the human ARF1 purified 
as shown in Fig. 8 failed to exhibit 
any nucleotide exchange activity, 
an active human ARF1(*) 
contributed by Mölleken J 
(personal communication) was 
tested for comparison with the 
yeast ARF1p. 
α  is the coefficient of 
proportionality between the 
fluorescence intensity and the 
concentration of ARF1p-GTP. 
Data are mean of 2 experiments.
 
 
With the various components of a reconstitution system at hand, we attempted to 
generate COPI coated vesicles from liposomes. 
3.2 Attempts to generate COPI coated vesicles from p23 
containing liposomes 
 
COPI coated vesicles can be generated from liposomes containing p23 
lipopeptide (Bremser et al., 1999). Purified proteins (ARF1 and coatomer) were 
incubated at 37°C with p23 containing liposomes. The reaction was stopped at 
0°C and submitted to a sucrose floatation gradient that typically yielded 
separation of donor liposomes (20 to 30 % sucrose (w/w)) and newly generated 
vesicles (40% sucrose (w/w)). Unreacted proteins (ARF1 and coatomer) were 
found at the bottom of the gradient (Fig. 27). The experiments shown in Fig. 27 
and 28 were performed with non gel filtrated liposomes. 
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Figure 27: Biochemical analysis of COPI vesicle formation from p23 containing liposomes. 
After separation by centrifugation in a sucrose gradient, fractions were analyzed by western 
blotting (A) using polyclonal rabbit antibodies directed against ARF1 and β’-cop (Helms et al., 
1993; Stenbeck et al., 1993). The percentage of sucrose was determined by refractometry.   
 
When the reaction was conducted at 0°C, coat components (ARF1 and 
coatomer) were not able to bind liposomes indicating a strict requirement for a 
physiological temperature (37°C). Furthermore, COPI coated vesicles were not 
generated at 0°C (no signal at a density of 40% sucrose). However, at 37°C, 
binding of ARF1 and coatomer occurs (signal in the donor liposome fraction) and 
coated vesicles were generated at 37°C as indicated by the signal of ARF1 and 
coatomer in the fractions at around 40% sucrose (Fig.27) 
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3.3 Attempts to generate COPI coated vesicles from liposomes 
 containing p23 and SNAREs 
 
 The question whether and how SNAREs are packaged into COPI coated 
vesicles was addressed using in principle the same methodology, however with 
liposomes that were reconstituted as described in Fig. 20  
GST-Sec22-FL and GST-Vti1p-FL containing liposomes (Fig. 20) were submitted 
to the budding assay in vitro (Fig. 28) 
 
 
Figure 28: Biochemical analysis of COPI vesicle formation from liposomes containing 
either GST-Sec22p-FL (A) or GST-Vti1p-FL (B). The same conditions as in Fig. 25 were used. 
Additionally, an antibody against GST (Sigma) allows detection of the GST-SNAREs.  
 
The SNAREs containing liposomes exhibit the same behavior as p23 containing 
liposomes when submitted to the budding assay. In fact no binding of coat 
components was observed at 0°C and a signal for ARF1 and coatomer was 
observed in the 40% sucrose fractions, indicating generation of COPI coated 
vesicles. In the same fractions, a signal for SNAREs was also observed 
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indicating their presence in COPI coated vesicles (fractions 7 and 8, Fig. 28). The 
relative faint signal of the SNAREs may be due to the fact they are not present as 
coat but as membrane components. It was established that budding efficiency is 
around 5% of the input of Golgi membranes in vivo (Malsam et al., 1999) and 
around 2% in vitro (Bremser et al., 1999). It is then not surprising to see such a 
weak amount of SNAREs in the coated vesicles. 
Moreover, it is not possible to rule out in these experiments that a part of the 
signals observed for ARF1, coatomer and SNAREs are due to coating of small 
liposomes rather than budding. Such coated liposomes might float to the same 
sucrose density. 
To address this question, large gel filtrated liposomes were made (Fig. 14) and 
submitted to the in vitro budding assay (Fig. 29) and compared with small 
liposomes (100 nm after extrusion). 
 As expected, when small liposomes were used, a signal for ARF1 and coatomer 
was found in the 40% sucrose region. Assuming these liposomes are too small to 
generate vesicles, this signal stands for mere binding of coat components. On 
the other hand, large liposomes show a similar signal at the same density (~ 40% 
sucrose). In this case, the signal can not be interpreted as mere binding of small 
liposomes as they do not exist in the starting material indicating de novo 
generation of COPI vesicles. 
This confirms the previous observation that the signal present when using non 
gel filtrated liposomes is due to binding of coat components to small liposomes 
as well as to newly generated COPI vesicles. 
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Figure 29: Biochemical analysis of COPI vesicle formation from large liposomes compared 
with small ones. Large liposomes (over 300 nm) containing p23 lipopeptide obtained after gel 
filtration were incubated with rabbit coatomer, human ARF1 and GTP-γS as a nucleotide. After 
incubation at 0°C (A) and 37°C (B), the reaction was separated in a sucrose gradient and 
analyzed by western blotting using polyclonal rabbit antibodies directed against β’-cop and ARF1. 
Small liposomes (extruded using 100 nm filters) were submitted to the budding assay. At 0°C (C), 
no signal is observed for donor fractions. At 37°C (D), a signal for coatomer and ARF1 is 
observed vesicles fractions.   
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COPI vesicle formation from Golgi membranes involves 3 major protein players, 
the small GTPase ARF1, coatomer and the p24 family proteins. ARF1-GTP 
interacts with two subunits of coatomer (β-cop and γ-cop) (Zhao et al., 1997; 
Zhao et al., 1999) and the p23 cytoplasmic domain is able to bind γ-cop (Harter 
and Wieland, 1998). To identify the minimal machinery that allows formation of 
COPI coated vesicles, a liposome based assay was established that includes the 
cytoplasmic tails of p24 family proteins, coatomer and ARF1. After incubation at 
37°C in presence of GTP, COPI coated vesicles were generated that resemble in 
their morphology and size the authentic ones (Bremser et al., 1999).  
On the other hand the minimal requirements for fusion of vesicles were also 
determined in a liposome based manner largely by the work of Rothman and 
coworkers. SNARE pins were shown to be the minimal machinery for cellular 
membrane fusion (Weber et al., 1998). Among different v/t-SNARE combinations, 
only few were able to trigger fusion (McNew et al., 2000a). In fact, bringing the 
membranes close enough is not sufficient for fusion to occur unless cognate 
SNAREs (v and t) are present in two populations of liposomes (McNew et al., 
2000b). 
The work described in this thesis has attempted to provide tools to allow linking 
the budding of COPI vesicles to the fusion machinery proteins (SNAREs). An in 
vitro system using chemically defined components (liposomes and purified 
proteins) was used for that purpose. 
One part of this work was dedicated to produce the set of proteins involved in 
coat assembly, namely coatomer and ARF1 (mammalian and yeast). In addition 
SNARE proteins were purified and included in liposomes. Are SNAREs packaged 
into newly formed COPI vesicles in a liposomes based system? To what extent 
does this take place? These questions were addressed in this work. 
In the second part, conditions in which homogenous population of large donor 
liposomes can form were found and a size separation allowed selection for large 
liposomes. 
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1 Protein components involved in COPI vesicular 
 transport 
 
1.1 SNARE proteins reconstituted in liposomes 
 
SNARE proteins were produced in bacteria, purified and reconstituted into 
liposomes using two methods. The first allowed anchoring the cytoplasmic 
domain of SNAREs to liposomes and will allow studying the possible interactions 
either with coat components or with additional cytosolic factors that might be 
involved. The second method (dilution under the detergent CMC, followed by 
dialysis) allowed reconstitution of full length SNAREs into liposomes in a way that 
resembles the situation of these proteins in vivo. Indeed, SNAREs seem to keep 
a natural orientation in liposomes since they are accessible for thrombin protease 
at the outer side of the liposome.  
Following the finding that sphingomyelin and cholesterol were segregated during 
formation of COPI coated vesicles (Brugger et al., 2000), the authors postulated 
that preferential interactions of certain membrane phospholipids with parts of the 
protein machinery mediating COPI vesicles formation might explain this lipid 
segregation. In this context, and as long as SNAREs interact with COPI 
components (Ballensiefen et al., 1998; Xu et al., 2002), in vitro studies should 
allow verifying whether they are involved in such a phenomenon.  
1.2 p24 family proteins 
  
The p24 family of type I transmembrane proteins play a major role in vesicular 
transport. They were shown to cycle constitutively in the early secretory pathway 
(Dominguez et al., 1998; Fullekrug et al., 1999; Nickel et al., 1997; Sohn et al., 
1996) and interact with ARF1-GDP (Gommel et al., 2001) and coatomer (Harter 
and Wieland, 1998). Since the interaction with coatomer is mediated by the 
cytoplasmic tail of p23, usage of p23 lipopeptide was made and has allowed 
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efficient budding of COPI coated vesicles in vitro regardless of the lipid 
composition (Bremser et al., 1999). However, the luminal part of p24 family 
members is important as it was shown to be responsible for the dimerization 
state of these proteins (Emery et al., 2000) and proposed to bind cargo 
(Schimmoller et al., 1995). It was possible in the current study to express and 
purify these proteins in their full length native form. This should allow 
investigation of the role of their transmembrane domain in interactions with lipids 
on one hand and their luminal domain in cargo uptake on the other hand. 
 
1.3 ARF1 GTPase activating protein (ARF1-GAP) 
 
It is known that ARF1 mediated GTP hydrolysis is required for COPI coat 
disassembly (Tanigawa et al., 1993) allowing the uncoated COPI vesicle to fuse. 
Since the GTPase activity of ARF1 is intrinsically low, ARF1-GAP remarkably 
accelerates this reaction (Cukierman et al., 1995). In addition coatomer increases 
this reaction 1000-fold through interaction with ARF1 and ARF1-GAP (Goldberg, 
1999).  
When expressed in bacteria, ARF1-GAP is insoluble. Attempts to obtain a 
soluble, refolded and active protein seem to be a challenge for many groups. 
Although refolded (Poon et al., 1996), Glo3p (a yeast ARF1-GAP) is unable to 
trigger GTPase activity of yeast ARF1 (Anne Spang, personal communication). 
In addition the catalytic domain of ARF1-GAP was recently shown to trigger 
uncoating of COPI vesicles (Reinhard et al., 2003) without affecting coat 
assembly, ruling out the possibility that ARF1-GAP acts as a coat component as 
suggested recently (Yang et al., 2002). 
In the context of reconstituting one round of COPI vesicular transport (budding, 
uncoating and fusion) using purified components, usage of a full length active 
GAP is of importance. The current work has allowed the purification of Glo3p, a 
yeast ARF1-GAP, from inclusion bodies, and refolding by gel filtration 
experiments led to a biologically active protein that is able to promote significant 
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ARF1p dependent GTP hydrolysis as shown by nucleotide exchange assays 
monitored by tryptophan fluorescence.   
 
1.4 ADP-ribosylation factor 1 (ARF1) 
 
ARF1 is a member of GTP binding proteins that regulate membrane traffic 
(Donaldson and Klausner, 1994; Schekman and Orci, 1996). It is present in the 
cytosol in a GDP bound state. Upon exchange of GDP to GTP on ARF1, a 
reaction accelerated by nucleotide exchange factors (Chardin et al., 1996; 
Jackson and Casanova, 2000; Peyroche et al., 1996) ARF1 changes its 
conformation and stably anchors to the membrane through its myristic acid 
(Goldberg, 1998). Prior to nucleotide exchange, ARF1 is recruited to the 
membrane by interacting with the p23 cytoplasmic tail (Gommel et al., 2001) 
regarded since then as ARF1-GDP receptor. In addition, ARF1 was shown to be 
necessary and sufficient to promote COPI vesicle formation from chemically 
defined liposomes (Bremser et al., 1999). 
The N-terminus of ARF1 is subject to the covalent attachment of a myristoyl 
group (C14:0) to its N-terminal glycine residue that is catalyzed by N-
myristoyltransferase1 (NMT1) (Towler et al., 1987) after removal of the initiating 
methionine by a bacterial Methionone amino peptidase. N-myristoylation is a very 
important modification since it confers to ARF1 the ability to stably anchor to 
membranes.  
Myristoylation of human ARF1, when expressed in a dual plasmid system 
together with yeast NMT1,  typically resulted in 5 to 10% myristoylation (Duronio 
et al., 1990) that can be increased up to 20% by lowering the temperature during 
expression. One explanation for the low degree of myristoylation is that human 
ARF1, although 77% identical to its yeast homolog is not an optimal substrate for 
yeast NMT1. Interestingly, it was recently demonstrated that human ARF1 is not 
fully myristoylated when co expressed with human NMT1 and NMT2 (Van 
Valkenburgh and Kahn, 2002). 
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Yeast ARF1p was then cloned and expressed with yeast NMT1 in E. coli either in 
a dual plasmid system or in a bicistronic system in presence of myristic acid. In 
both cases, purity to apparent homogeneity was achieved by ammonium sulfate 
precipitation and cation exchange chromatography. Expression and purification 
of yeast ARF1p in absence of NMT1 and myristic acid was conducted to provide 
a non myristoylated ARF1p as control. 
As shown by Franco and coworkers (Franco et al., 1995) for the bovine ARF1 
(100% identical in protein sequence to the human one) after expression at 37°C, 
three bands of ARF1 with increasing mobility in SDS-PAGE are present that 
correspond to Met1-ARF1 (intact ARF, non myristoylated and uncleaved by 
Methionine amino peptidase), Gly1-ARF1 (formed by cleavage of the N-terminal 
Met) and myr-ARF1 (myristoylated ARF1).  
When non myristoylated yeast ARF1p was purified, the large majority of the 
protein was cleaved (Gly1-ARF1) while a small part, appearing as a faint band, 
was observed that represented Met1-ARF1 (Lane 3, Fig. 8) 
When yeast ARF1p was co-expressed with NMT1 in presence of myristic acid, 
only one band could be observed that runs the fastest on SDS-PAGE (Lanes 1, 2 
and 4, Fig. 8) and corresponds to myr-ARF1p. In addition, different salt 
concentrations were needed to elute the proteins from a cation exchanger (~100 
mM NaCl for myr-ARF1p and ~200mM for the non myristoylated protein). 
Moreover, myristoylated ARF1p was able to exchange GDP to GTP only in 
presence of liposomes while the non myristoylated ARF1p could exchange 
nucleotide either in presence or in absence of liposomes with similar efficiency. 
Since these two ARF1p behave differently on SDS-PAGE, in cation exchange 
chromatography and in exchange of nucleotide, the data presented here 
unambiguously show that full myristoylation of yeast ARF1p was achieved under 
the described conditions.  
Based on the data described here, myristoylation seems necessary but not 
sufficient to achieve full nucleotide exchange activity on liposomes since the non 
myristoylated ARF1p is active both in presence and absence of liposomes. 
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2 In vitro budding assay with liposomes mimicking 
 Golgi membranes 
 
A minimal system that contains liposomes and purified components has been 
used to address fundamental questions in the field of vesicular transport. It was 
shown that Sar1p, COPII proteins and GTP were the minimal components 
needed to pinch off COPII coated vesicles from acidic liposomes (Matsuoka et 
al., 1998b). On the other hand, COPI coated vesicles were generated from 
synthetic liposomes using ARF1, coatomer and GTP-γ-S (a non hydrolysable 
analogue of GTP) (Spang et al., 1998). However in this study, usage was made 
of acidic lipids that are more representative of yeast microsomal membranes 
(Wagner and Paltauf, 1994; Zinser and Daum, 1995) rather than mammalian 
membranes (Fleischer et al., 1974; Howell and Palade, 1982; van Meer, 1998) 
suggesting that additional components might be needed for budding.  
An in vitro budding assay was developed that requires ARF1, coatomer, GTP-γ-S 
and liposomes whose composition resembles Golgi membranes and that contain 
cytoplasmic tails of p24 family proteins. In this system, de novo generation of 
COPI vesicles was shown and a crucial role was attributed to p24 family tail 
peptides since no budding occurs in absence of this component (Bremser et al., 
1999).  
This assay was used to investigate the behavior of SNAREs in COPI vesicles. 
2.1 Behavior of SNAREs in the COPI in vitro budding assay 
 
SNAREs were reconstituted into Golgi like liposomes containing p23 tail peptide. 
In vitro budding assay was conducted with liposomes containing Sec22p 
(implicated in ER-Golgi transport (Xu et al., 2002)) and Vti1p (implicated in Golgi 
retrograde traffic (Lupashin et al., 1997)). 
By submitting SNARE and p23 containing liposomes to the in vitro budding 
assay, COPI coated vesicles were formed and run at 40% sucrose (w/w) after 
flotation in a sucrose gradient exactly as the p23 containing liposomes do. 
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Furthermore, after quantification of the lipid content of the donor liposomes pool 
and the vesicles pool, and by loading the same amount of each pool on SDS-
PAGE and analysis by western blotting, it was possible to address the question 
whether SNAREs concentrate in COPI vesicles in vitro. In fact, no difference was 
observed between the 0°C and the 37°C reactions indicating GST-Sec22p-FL 
and GST-Vti1p-FL do not seem to be preferentially taken up in COPI vesicles in 
vitro. By usage of a similar liposome based system, Sec22 was shown to be 
concentrated in COPII vesicles (Matsuoka et al., 1998a) confirming its implication 
in fusion of COPII vesicles. 
In vivo, Sec22 is associated with the pre Golgi intermediate compartment (Zhang 
et al., 1999) and recycles back from Golgi to the ER in a manner involving COPI 
components (Ballensiefen et al., 1998). On the other hand, Sec22b is shown to 
be enriched in COPII coated vesicles that bud from the ER and presumably fuse 
with nearby vesicular tubular clusters (VTCs)(Hay et al., 1998). Moreover, In vivo 
data have shown that Vti1p exists in a SNARE complex that contains Sed5, 
GS28, and Ykt6, all implicated in both ER-to-Golgi and intra-Golgi transport (Xu 
et al., 2002), and in vitro can be immunoprecipitated with COPI coat components.  
In vivo these two proteins interact with COPI components and are present in 
complexes with other SNAREs. In addition the ARF-GAP Glo3p was shown to 
mediate an interaction of v-SNAREs to COPI components using microsomal 
membranes (Rein et al., 2002). 
Taking this into account, it may well be that concentration (or segregation) effects 
using the in vitro budding assay could be seen more clearly when these SNARE 
complexes are reconstituted in liposomes and subjected to the budding assay. In 
that respect, preliminary experiments have allowed reconstitution of a complex of 
Sec22, Bos1 and Sed5 in liposomes and further experiments should dissect the 
mode and requirements for specific uptake of SNAREs in pre budding structures. 
These experiments can now be complemented by the active ARF-GAP Glo3p to 
test its ability to mediate recruitment of COPI components to SNAREs. 
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Liposomes as a model for donor membranes characterized by DLS and electron 
microscopy revealed that the starting liposomes contained a mixed population of 
large and small structures. When coated, the small liposomes may be 
indistinguishable from the newly formed vesicles on the flotation gradient. Thus 
signals observed for coat proteins (ARF1 and coatomer) in the 40% sucrose 
region could then be due mainly to binding of coatomer and ARF1 to preexisting 
small liposomes, and not to newly generated COPI vesicles. On the other hand, 
large liposomes offer a higher surface for budding and are therefore suitable to 
yield a higher budding efficiency. 
Therefore it seemed important to obtain quite homogenous populations of large 
liposomes as starting material for the in vitro budding assay. 
 
2.2 Generation of large liposomes 
 
Establishing conditions to obtain large liposomes of a defined size was a 
challenging task in this work.  
Unilamellar liposomes can be formed by reverse-phase evaporation techniques 
(Szoka and Papahadjopoulos, 1978; Timofeev et al., 1994). This method requires 
long preparation times, and involves mixing between organic and aqueous 
phases that is prone to denature proteins. With another method giant unilamellar 
vesicles (GUVs) are generated by exposing dried lipid films to aqueous solutions 
for long time hydration (Mueller et al., 1983). A modified method that uses low ac 
electric fields allows preparation of GUVs and requires special instrumentation. 
Avoiding these experimental limitations, Takei and coworkers; (Kinuta and Takei, 
2002; Kinuta et al., 2002; Takei et al., 2001) have described a procedure to 
generate large liposomes with a size larger than 1000 nm diameter using a 
gentle hydration method. In addition, they were able to see small vesicles 
generated after budding. During this work, the same procedure to obtain 
liposomes was used, but failed to achieve similar results, although this method 
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allowed improvement of the standard protocol. However, DLS measurements 
revealed the presence of additional small liposomes (~100 nm). 
The current work describes separation of large liposomes (≥300 nm) from small 
ones by size exclusion chromatography. Typically large liposomes represent 10% 
of the starting material and can be concentrated by centrifugation since they were 
formed in a buffer containing 2.5% sucrose (w/w). 
Use of such liposomes in the in vitro budding assay yielded a signal in the 40% 
sucrose fractions that is higher than the one generated with small control 
liposomes. This indicates that small liposomes bind coatomer and ARF1 indeed, 
and they are present together with newly generated COPI vesicles in the same 
40% fractions. This confirms that a part of the signal observed using standard 
non gel filtrated liposomes is a contamination caused by small preexisting 
liposomes, and emphasizes a need to use purified large liposomes as a starting 
material. Taking this into account, quantifying amounts of SNAREs taken up in 
newly generated COPI vesicles in future experiments will need to be performed 
with liposomal donor membranes carefully defined by the criteria described here. 
Usage of gel filtrated liposomes should allow addressing this question. 
Taken together, the results shown here have contributed to improve the 
individual components needed for COPI vesicles biogenesis in vitro. Biologically 
active yeast ARF1p and its ARF-GAP, Glo3p were made available and SNAREs 
can be included into liposomes in their correct physiological orientation. 
In addition, a protocol to prepare a homogenous population of large liposomes 
(over 300 nm) was established. 
With all these components in hand, it should now be possible to study the uptake 
of SNAREs in COPI vesicles in vitro as well as protein and lipid cargo uptake. 
Eventually this should allow the reconstitution of a full round of COPI vesicular 
transport from budding to fusion.  
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Materials 
1 Chemicals 
All commonly used chemicals were purchased from either Merck (Darmstadt), 
Sigma (Deisenhofen), Roth (Karlsruhe), Fluka (Taufkirchen), Roche (Mannheim), 
Qiagen (Hilden), Amersham-Biotech (Freiburg), BioRad (Mϋnchen) or Boehringer 
(Mannheim). The reagents were ordered directly at the company or via the 
chemical centre Heidelberg (Theoretikum der Universität Hiedelberg).  
 
1.1 Detergents 
Triton X-100, octyl glucoside (OG) were obtained from Merck and Calbiochem, 
respectively.  
 
1.2 Protease inhibitors  
 
Mixtures of protease inhibitors were obtained from Roche as tablets. Each tablet 
was sufficient for a 50 ml solution. 
1.3 Buffers 
A List of most commonly used buffers during this experimental work is shown 
below. All buffers were prepared as aqueous solutions. 
 
PBS buffer 
10X PBS: 1.36 M NaCl, 357 mM Na2HPO4, 143 mM KH2PO4 and 30 mM KCl.  
PBST was obtained by mixing PBS buffer supplemented with Tween-20 to 0.05% 
final concentration.  PBS was adjusted to pH 7.4. 
 
TAE buffer 
50X TAE contained 242 g Tris base, 57.1 ml of glacial acetic acid and 18.61 g of 
EDTA, and adjusted to 1 L solution with MiliQ H2O. 
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Running buffer for electrophoresis 
10X SDS-PAGE running buffer contained 30.2 g Tris base, 188 g of glycine and 
10 g of SDS, and adjusted to 1 L solution with MiliQ H2O.  
 
Blotting buffers for semi-dry transfer 
Anode I: 300 mM Tris and 20% (v/v) methanol. 
Anode II: 25 mM Tris and 20% methanol.  
Cathode buffer: 25 mM Tris, 40 mM aminocaproic acid and 20% methanol. 
 
Sample cocktail buffers 
Sample buffer for DNA: 6X stock solution contained 0.25% bromophenol blue, 
40% sucrose, 60 mM Tris-HCl, pH7.4 and 6 mM EDTA.  
Sample cocktail I (SCI): 50 mM Tris-HCl pH 6.8 and 4% SDS  
Sample cocktail II (SCII): A 3X stock solution contained 187.5 mM Tris-HCl 
pH6.8, 15% β-mercatoethanol, 6% SDS, 30% glycerol and 0.0675% 
bromophenol blue. 
 
Staining Solution for SDS-PAGE 
Staining buffer: 40% ethanol, 10% glacial acetic acid and 0.25% coomassie 
blue R-250. 
Destaining buffer: 20% ethanol and 5% acetic acid. 
Ponseau S solution: prepared by adding 0.8g of the dye dissolved in 4% (w/v) 
TCA. 
 
1.4 Media 
Bacteria and yeast culture media 
 
Lauria-Bertani broth (LB) was prepared according to guidelines of Molecular 
Cloning (3rd Edition). 1 L of medium contained 10 g of sodium chloride, 10 g of 
Bacto-Trypton and 5 g of yeast extract. pH was adjusted to 7.4. For plates, 15 g/L 
agar was added to the preparation. 
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YPD medium was prepared as follows: 10 g of BactoYeast extract, 20 g of 
BactoPeptone and Dextrose were dissolved in 1 L of MilliQ water and 
autoclaved. 
 
YPD 
 
20g of peptone, 10g of yeast extract and 20g of D-glucose were dissolved in 1 
liter of miliQ water and autoclaved for 15 minutes at 120 °C. For plates, 15 g/L 
agar was added to the preparation. 
 
Xgal plates  
LB-agar plates were prepared as described earlier and X-Gal. 100µl of 100mM 
IPTG and 20µl of 50mg/ml X-Gal (dissolved in N,N´ dimethylformamide ) were 
spread over the surface of the LB-plate and allowed to absorb for 30 minutes at 
37°C prior to use. 
2 Antibodies 
2.1 Primary Antibodies 
 
For the immunochemical studies the following antibodies were used: 
1 GST antibody for detection of GST fused SNAREs (rabbit) (Sigma).  
2 p23 tail peptide antibody (rabbit).  
3 Human ARF1 antibody (rabbit).  
4 β’-cop antibody (rabbit). 
5 γ-cop antibody (rabbit). 
2.2 Secondary Antibodies 
 
HRP-conjugated goat anti-rabbit IgG(H+L) and HRP-conjugated goat anti-mouse 
IgG(H+L) were obtained from BioRad. HRP-conjugated Protein G Sepharose 
Beads was purchased from BioRad. 
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3 Plasmids 
 
The following plasmids were used during this work various purposes as indicated 
below:  
pbb131 (Duronio et al., 1990). Expression of N-myristoyl transferase in E. 
Coli to that transferes the myristic acid to ARF1. 
pGEX used for cloning of  SNAREs as GST fusions (Amersham 
biosciences). 
 Full length SNAREs (FL) were cloned as well as their cytoplasmic 
domains (CD) to which a cystein was added at the C-terminus: 
 pGEX-Sec22p-FL, pGEX-Sec22p-CD 
 pGEX-Gos1p-FL, pGEX-Gos1-CD 
 pGEX-Bet1p-FL, pGEX-Bet1-CD 
 pGEX-Vti1p-FL, pGEX-Vti1p-CD 
 pGEX-Bos1p-FL, pGEX-Bos1-CD 
 pGEX-Ykt6p-CD (Ykt6 does not have a transmembrane domain 
and therefore was made available with an additional cystein)  
pET11d (Novagen). Was used that contains human ARF1, pET11d-hARF1 
pET-24 a (+)  (Novagen). Was used to clone native yeast ARF1p: pET-24 a-
ARF1p 
pET-32 Xa/LIC (Novagen). was used to clone the human p23 protein tagged to 
thioredoxin, 6XHis and S protein tag: pET-32 Xa/LIC-p23 
pACYCDuet-1 (Novagen). Bicistronic vector used to clone NMT1 alone: 
pACYDuet-1-NMT1 and both NMT1 and ARF1p: pACYDuet-1-
NMT1-ARF1p 
pET-15 a (+) (Novagen). Was used to clone Glo3p fused to a 6XHistidine Tag: 
pET15 a-Glo3p 
4 Oligonucleotides 
The oligonucleotides used in this thesis were synthesized by Thermohybaid 
(formally Interactiva) (HPLC grade). All oligonucleotides were solubilized in 
sterilized water to a final concentration of 100µM. All sequences are presented in 
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table 3. 
 
Designation Sequence ( 5’-3’) 
GST-Sec22-
FL-Nter 
gcgcggatccatgataaagtcaacactaatctacag 
GST-Sec22-
FL-Cter 
cccggaattcttatttgaggaagatccaccagaag 
GST-Sec22-
CD-Cter 
cccggaattcttagcaatcgaagttgatcttttgcgcg 
GST-Gos1-
FL-Nter 
gcgcggatccatgagctcacaaccgtctttcgtcacc 
GST-Gos1-
FL-Cter 
cccggaattcttattaccatgtgaaaaacaaaaacag 
GST-Gos1-
CD-Cter 
cccggaattcttagcagtttttcttccttctcgtg 
GST-Bet1-FL-
Nter 
gcgcggatccatgagttcaagatttgcaggg 
GST-Bet1-FL-
Cter 
cccggaattcttattatgtaatccataccc 
GST-Bet1-
CD-Cter 
cccggaattcttagcattttatactgatcccagatcttc 
GST-Vti1p-
FL-Nter 
gcgcggatccatgagttccctattaatatcatacg 
GST-Vti1p-
FL-Cter 
cccggaattcttattattaaactttgagaacaaaac 
GST-Vti1p-
CD-Cter 
cccggaattcttagcatttattagcaactagccttctag 
GST-Bos1-
CD-Nter 
gcgcggatccatgaacgctctttacaaccatgctgtg 
GST-Bos1p-
CD-Cter 
ctcccccgggttagcatttatctttgaacacccg 
GST-Ykt6p-
Nter 
gcgcggatccatgagaatctactacatcggtgtatttcg 
GST-Ykt6p-
Cter 
cccggaattcttagcactacatgatgatgcaacacg 
pET24a-
ARF1p-Nter 
gggtttcatatgggtttgtttgcc 
pET24a-
ARF1-Cter 
gggtttggatccttaagttgagtttttc 
pET-32 
Xa/LIC-p23-
Nter 
ggtattgagggtcgcatgatctccttccatctgcc 
pET-32 
Xa/LIC-p23-
Cter 
agaggagagttagagccttattcaatcaacttcttgg 
pACYDuet-1-
NMT1-Nter 
gggtttccatggggtcagaagaggataaagcg 
pACYDuet-1-
NMT1-Cter 
gggaaaggatccctacaacataacaacacc 
pACYDuet-1-
ARF1p-Nter 
gggtttcatatgggtttgtttgcc 
pACYDuet-1-
ARF1p-Cter 
gggtttggatccttaagttgagtttttc 
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pET15 a-
Glo3p-Nter 
gggtttcatatgagtaacgatgaaggagaaac 
pET15 a-
Glo3p-Cter 
gggtttggatccttattttcttaagtagtcc 
 
Table 3. Oligonucleotides used to prepare constructs for cloning GST-fused yeast SNAREs, 
ARF1p, NMT1 and Glo3p   
 
5 Equipments 
 
PCR thermocycler was from ThermoHybaid, ultra-centrifuges were from either 
Beckman or Kontron Instruments (Watford, UK). Other centrifuges were from 
either Eppendorf or Heraeus. Rotors are from Beckman (JA-10.500, JA-20, JA-
25.50 and SW55 Ti) or Kontron (TFT 50-38 and 55-38). Electrophoresis systems, 
including plates, spacers and combs, and blot systems, including semi-dry trans-
blot and wet blot were from Bio-Rad (Munich, Germany) or Invitrogen 
(Karlsruhe). Cell incubators were from Heraeus.  
 
Methods  
6 Biochemical Methods  
6.1 Synthesis of p23 and p24 lipopeptides 
 
The p23 and p24 proteins tail peptides were synthesized at ZMBH, Heidelberg 
University, and lyophilized. The sequences of peptides are: 
 p23: CLRRFFKAKKLIE 
 p24: CLKRFFEVRRVV 
 
A commercially available phosphatidylethanolamine (PE) derivative 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine-n-[4-(malaeimidophenyl)butyramide] (MPB-
PE) was purchased from Avanti polar lipids. The maleimido group reacts with the 
free thiol group of the peptides cysteine to form a stable thioether. 
Prior to use, the cystein containing peptides were analyzed for their potential 
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oxidation of the cysteine thiol group that reacts to the MBP-PE lipid. According to 
the manufacturer recommendations (Pierce), Ellman reagent was used for that 
purpose and typically 70% of the peptides were found to have a functional 
reduced thiol group. 
 
Stock solutions:  
MPB-PE in chloroform:     25 mg/ml (24.75 mM) 
p23 and p24 peptides solubilized     4mg/ml (2.2 mM)  
in dimethylformamide (DMF)  
 
MPB-PE (500 nmol) is added to a glass vial and solvent was removed under a 
gentle stream of Argon. Depending on the degree of oxidation of p23 peptide 
(typically 30%), suitable amount of p23 peptide dissolved in dimethylformamide 
(DMF) was added to the lipid film (10% excess of peptide over MPB-PE) and this 
mixture was kept at least 4 hours on a rotating wheel. Free maleimido groups 
were quenched by addition of 1 µmol of β-mercaptoethanol. The mixture was 
dried under argon and the sample was resuspended in 1ml 30% Acetonitrile (AN) 
/ 0.1% trifluoroacetic acid (TFA).  
Sep-Pak C18 cartridges were used to purify the lipopeptides. Cartridge was 
washed with 1 bed volume (1ml) of 100% AN / 0.1% trifluoroacetic acid (TFA) 
and equilibrated with 30 ml of 30% AN/ 0.1% TFA before loading the sample. The 
cartridge is then submitted to a step gradient that consists of 2 ml of 30% AN / 
0.1% TFA, 2 ml of 40% AN / 0.1% TFA, 2 ml of 60% AN / 0.1% TFA, 2 ml of 80% 
AN / 0.1% TFA, 4 ml of 90% AN / 0.1% TFA and 2 ml of 100% AN / 0.1% TFA. 
p23 lipopeptide elutes at 80% and 90% AN / 0.1% TFA while p24 lipopeptide 
elutes at 90% and 100% AN / 0.1% TFA (Fig. 16) 
Each fraction is lyophilized and dissolved in 200 µl 30% AN / 0.1% TFA and 10µl 
were analyzed by thin layer chromatography (standard silica gel 60 plates (20x20 
cm) (Merck). The solvent used is a mixture of butanol, pyridine, acetic acid 
(glacial) and water (9.7:7.5:1.5:6;v:v:v:v). Silica plates are developed for 3 hours, 
then dried and placed in a chamber containing solide iodine that stains lipids and 
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lipopeptides. Peptides were also stained due to their hydrophobic amino acids 
(two phenylalanine residues). 
After quantification of the phosphate content (see 6.5), aliquots of 15 nmol 
lipopeptide were dried and stored under argon at -80°C. 
6.2 Preparation of p23 lipopeptide containing liposomes 
 
To prepare liposomes, lipids were used that resemble the Golgi lipid composition: 
PC (phosphatidyl choline)    42% 
PE (phosphatidylethanilamine)   19% 
PS (phosphatidylserine)    5mol% 
PI (phosphatidylinositol)    10mol% 
SM (sphingomyeline)    7 mol% 
Cholesterol      16 mol% 
Rhodamine-PE (fluorescent lipid tracer)  1mol% 
 
Liposomes were prepared in glass tubes previously rinsed with chloroform. 100µl 
of a stock lipid solution (300 nmol in total) were added to 15 nmol lipopeptide and 
transferred to a glass tube. The solvent was removed under an argon stream. 
Liposomes form after addition of 300 µl of an aqueous buffer (25 mM Hepes-
KOH (PH=7.4), 150 mM KCl, 2.5% Sucrose (w/v)) and kept at 37°C for 2 hours. 
The sample was then subjected to 10 cycles of freezing (liquid nitrogen, -180°C) 
and thawing (50°C in a water bath). 
The suspension was extruded through polycarbonate membrane of a defined 
size (800nm) (Avestin extruder) by 21 passages through 2 membranes.  
 
6.3 Electron microscopy 
 
Negative staining was used for electron microscopy (Valentine et al., 1968). 
Liposomes are allowed to adsorb onto the surface of a carbon support film 
previously deposited onto a piece of cleaved mica. A 3x3 mm piece of carbon 
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coated mica was cut and inserted in an angle into the liposomes suspension. The 
carbon film floats off the mica but by holding the mica with fine tweezers it still 
remain attached at one corner. When the mica is removed from the liposomes 
suspension the carbon film is brought with it, sandwiching the particles between 
mica and carbon. Since liposomes remain attached to the carbon film, fixation 
with a solution of 1% (w/v) uranyl acetate was carried out, followed by washing 
with water. Careful drying with filter paper ensures that sufficient stain will remain 
to prevent a deformation of the two films.     
6.4 Selection for large liposomes by size exclusion 
 chromatography 
 
In addition to large liposomes (over 400nm), the liposomes obtained above 
contain also numerous small structures (below 100nm) as shown by electron 
microscopy and Dynamic Light Scattering (DLS). Gel filtration experiments were 
used to select only for the large ones. 
Sephacryl-1000 medium (Amersham biosciences) was used to pack a 55 ml 
column. Column was equilibrated with 3 bed volumes of the liposomes buffer (25 
mM Hepes-KOH (PH=7.4), 150 mM KCl) supplemented with 20 mg/ml BSA. 
Liposomes were loaded and eluted at 30% of the bed volume. As they contain 
Rhodamine-PE they were monitored by measuring the fluorescence of this 
component (λex=558 nm, at λem=592 nm) 
 
6.5 Quantification of lipids 
 
phospholipids can be quantified by measuring their phosphate content (Rouser et 
al., 1970) or by measuring the fluorescence of Rhodamine-PE. 
 
 Phosphate determination: 
 
Lipid samples are taken to dryness in the oven in capped glass tubes. 300µl of 
70% perchloric acid are added and the tubes are moved to a heating block at 
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180°C for 40 minutes. 1ml H2O, 0.4 ml Ammonium Molybdate (1.25 % (w/v)) and 
0.4 ml Ascorbic acid (5% (w/v)) are subsequently added and mixed after each 
addition. 
Samples are heated again 5minutes at 100°C. Absorbance at 797 nm is 
measured. Standard amounts of KH2PO4 (0, 4, 10, 20, 40, 60, 80 nmols) are 
subjected to the same procedure allow deduction of the phosphate amounts 
contained in the lipids tested (either liposomes or lipopeptides). The amount of 
cholesterol (16%) was subtracted since it is not a phospholipid. 
 
 Fluorescence measurements: 
 
To check the recovery of liposomes after gel filtration, 100µl of each fraction 
(volume 750 µl) was loaded in a 96 microplate spectrofluorometer (Spectra Max 
GeminiXS (Molecular devices)) and the fluorescence of Rhodamine-PE was 
measured by collecting the emitted fluorescence at λem=592 nm  after excitation 
at λex=558 nm. Rhodamine-PE containing liposomes of known amounts of 
phospholipids were used for standardisation. 
 
6.6 in vitro budding assay using p23 containing liposomes 
 and purified proteins 
 
Incubation mixture:  
 Component  Liposomes 
(10 nmol) 
 H2O  10 fold 
buffer* 
 GTP-γ-S 
(2mM) 
 
ARF1 
(2µg) 
 MgCl2 
(5mM) 
 
Coatomer 
(22 µg) 
p23 
liposomes at 
37°C 
 2.5   30.3  5  1  6.3  0.5  4.4 
p23 
liposomes at 
0°C 
 2.5  30.3  5  1  6.3  0.5  4.4 
*: 250 mM Hepes-HOH (PH 7.4), 1.5 M KCl, 25 mM MgCl2. 
 
After addition of ARF1, the sample is incubated for 40 minutes and then MgCl2 
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and coatomer are added and the incubation continues for an additional 40 
minutes. The reaction is then stopped by incubation at 0°C. As a control, the 
same reaction mixture is kept at 0°C. 
The sample is then adjusted to 55% sucrose (w/w) in a final volume of 325 µl and 
placed in a SW55 rotor centrifugation tube. Sucrose solutions (w/w) were added 
as follows: 500µl of 50%, 500µl of 45%, 500µl of 40%, 500µl of 30%, 500µl of 
20%. Membranes are floated by ultracentrifugation at 150,000g for 4 hours at 
4°C and the gradient is fractionated from the top (light fractions) to the bottom 
(heavy fractions) in 11 fractions of 256µl.  
Biochemical analysis of these fractions was carried out by western blotting using 
antibodies against ARF1 and β’-cop. 
 
6.7 Tryptophan fluorescence assay 
 
The tryptophan fluorescence experiments were done using a fluoremeter from 
JASCO (FR-6500) and the temperature was set to 37°C. In a fluorescence 
cuvette, 530 µl of Hepes buffer (Hepes-KOH, pH 7.4, KCl 150 mM, MgCl2 2mM) 
were added, followed by addition of 60µl of liposomes (Golgi like). Once the base 
line was stable (1 minute), ARF1 was added (amounts for each experiment are 
indicated in ”Results”), 5µl of a solution of 10 mM GTP, then 6µl of a stock 
solution of 400mM EDTA. Either MgCl2 (6µl of a stock solution of 400mM) or 
Glo3 (1µg) were added (see results). Tryptophan was excited at λex=297.5 nm 
and emitted at λem=340 nm. 
Data were collected using software from JASCO and fitted to exponential curves 
using a Prism4 (GraphPad).    
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6.8 Liposomes size determination by dynamic Light  Scattering 
(DLS) 
 
Experiments were performed using DLS equipment from MALVERN 
INSTRUMENTS (ZetaSizer S1000 HAS,10 mW max, output He Ne; 633 nm). 
This technique measures the particle diffusion due to Brownian motion (random 
movement of particles due to the bombardment by the solvent molecules that 
surround them) and relates this to the size of the particle. The parameter 
calculated is defined as the translational diffusion coefficient (D). The particle size 
is then calculated from D using the Stoke-Einstein equation; d(H)=(kT)/(3πηD), 
where d(H) is the hydrodynamic diameter, k is the Boltzman’s constant, D the 
translational diffusion coefficient, T the absolute temperature and η the viscosity. 
The DLS equipment produces a correlation of the particle position decay based 
on its movement. Since a large particle diffuses slower than a smaller one, the 
decays are different and a mathematical model correlates this decay to the size 
of the particle.  
Measurments were performed at a constant temperature (25°C) because the 
viscosity of a liquid is related to its temperature. Samples were diluted and 
loaded in fluorescence cuvette. 12 measurements of 10 seconds each were 
performed. The mode chosen was continuous and the detection angle is at 90°C. 
Three detection modes are available (Intensity, Volume and number). Only the 
number mean was taken into account since it was in perfect accordance with the 
size given by electron microscopy experiments. 
 
7 Methods in Molecular Biology 
7.1 Preparation of yeast genomic DNA 
 
Yeast Saccharomyces cerevisiae was grown in 5ml YPD medium until an OD 
between 1 and 3. The culture was spun down 5 minutes at 2000g and washed 
with 10 ml water. After washing, the cells pellet was resuspended in 500µl water 
followed by addition of 200 µl a detergent mix (100mM NaCL, 10mM Tris-HCl pH 
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8.0, 1mM EDTA, 2% Triton X-100, 1% SDS, sterile filtered). Glass beads (0.1 to 
0.2 ml) as well as 300µl of a 1 to1 mixture of Phenol and chloroform were added. 
After vortexing, the lysate was pelleted and soluble material was transferred to a 
2ml cup. A 2.5-fold volume of 100% ethanol was added, thoroughly mixed and 
DNA was precipitated at -20°C for 10 minutes. After centrifugation at 10,000g, 
the pellet was dried and resuspended in 400µl of Tris-HCl buffer (10mM Tris-HCl, 
pH 8.3). After addition of 200µg of RNAse A, sample was incubated at 37°C for 
40 minutes. Genomic DNA was finally precipitated by addition of NaCl (3M) and 
cold ethanol (100%). Yeast genomic DNA was pelleted at 10,000g for 10 
minutes. The pellet was then dried and resuspended in 30µl of a Tris-HCl buffer 
(pH 8.3). 
7.2 Polymerase chain reaction (PCR) 
 
All reactions were carried out according to the manufacturer’s guidelines. The 
reaction volumes were 50 µl, using the PfuTurbo polymerase (Stratagene). The 
reaction mix contains the following components: 5 µl of 10 X reaction buffer 
(Stratagene), 2 µl (0.1 µg) of yeast genomic DNA, 1.25 µl of each oligonucleotide 
(100 ng/µl), 1 µl of dNTPs (0.2mM), 1 µl of PfuTurbo (2.5  U/µl), and MilliQ water 
to adjust the total volume to 50 µl. All PCR reactions were initiated with 1 cycle at 
95°C for 30 sec, followed by 20 to 30 cycles starting at 95oC for 30 sec, 55oC for 
1 min, and 68oC for 2 min. 
The annealing reaction was performed at appropriate temperatures (based on 
different primer pairs (Table 3)). in principle 5°C lower than the Tm of the primers 
for 30 - 60 sec. Elongation was performed at 68°C for 2 min (PfuTurbo amplified 
at 2 min/kb. In all cases, the reactions were performed for 30 cycles in the 
conditions indicated above. 5µl of PCR products were analyzed by agarose gel 
electrophoresis to ensure efficient amplification. Then, the PCR amplified 
fragments were purified from agarose gel slices with the use of Nucleobond 
extract kit (QIAGEN). Doubly digested plasmid vectors were also purified with 
this kit. Purified PCR products were directly used for cloning into the indicated 
vectors after digestion with restriction enzymes (double enzyme digestion). If the 
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two used enzymes could not work in the same buffer, the digestion mixtures were 
purified from gel, and the digestion repeated for the second enzyme.  
7.3 Ligations and subcloning  
 
All ligations reactions were carried out in a maximal volume of 20 µl with the use 
of the DNA ligation kit version2 (TAKARA biomedicals). This kit uses one solution 
that contains T4 DNA ligase and an optimized buffer system. A mixture 
containing the digested and purified PCR product and the plasmid of interest is 
added 1 to 1 to the kit solution and incubated at 16°C for 30 minutes. Typically, 
such incubation resulted in efficient transformation and numerous colonies grew. 
A volume of 5 µl of ligation mixtures was used to transform competent DH5-α 
(Invitrogen) for subcloning. Transformation was carried out by heat-shock. Briefly, 
50 µl of competent cells were mixed gently with 5 µl of ligation mixture and 
incubated on ice for 30 min. The cells were heat-shocked at 37°C for 20 
seconds, followed by incubation on ice again for 2 min. A volume of 1ml of pre-
warmed LB medium was added to the transformation mixture followed by 
incubation at 37°C for 1 hr with shaking. Cells were plated on LB agar plate 
containing appropriate antibiotics and incubated at 37°C overnight. 
Several colonies were randomly picked and inoculated into 4 ml of LB media 
supplemented with appropriate antibiotics. The cultures were incubated at 37°C 
for 16-18 hrs. Plasmid DNA extraction was done using QIAgen miniprep kit or 
Machery-Nigel nucleospin kit. The protocol of these two kits is basically the same 
(modified alkaline lysis). Briefly, cells were pelleted by centrifugation at 4000 rpm 
4°C for 10 min, and resuspended in 0.2 ml of solution I containing RNase. Cells 
were lysed by adding 250 µl of solution II, followed by mixing carefully the 
solution (upside-down movement for several times. The lysates were neutralized 
by the addition of 300 µl of solution III. The solution was cleared by 
centrifugation, and supernatants were loaded onto the binding column and spun 
down. The flow-through was discarded, and the columns washed with buffer PB 
and PE as indicated by the manufacturer. In the last wash, centrifugation was 
performed for 2 min to remove traces of ethanol. The plasmids were eluted with 
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50 µl MilliQ water sterile. All recombinant plasmids were identified by digestion 
with appropriated enzymes and confirmed by commercial DNA sequencing 
(SeqLab GmbH). 
 
8 Protein expression and purification 
8.1 Endogenous rabbit coatomer 
 
Rabbit liver (30 to 40g) is cut into pieves by a scalpel. All subsequent steps are 
carried out at 4°C. It is then homogenized using a waring blender (3x20 seconds) 
in the following buffer (buffer A): 
25 mM Tris-HCl (pH 7.4), 500 mM KCl, 250 mM sucrose, 2 mM EGTA, 1mM 
DTT, protease inhibitor tablets (Roche). 
The homogenate was centrifuged at 10,000g for 1 hour and filtrated through 
cheese cloth. After two additional centrifugations at 100,000g, the supernatant is 
filtrated again through cheese cloth.  
The sample is fractionated by Ammonium sulfate precipitation at 35% saturation. 
After stirring for 60 minutes, the precipitate is recovered by centrifugation at 
8,000g for 30 minutes and resuspended in 100 ml of the following buffer (buffer 
B): 
25 mM Tris-HCl (pH 7.4), 200 mM KCl, 1 mM DTT, 10% (w/v) Glycerol, protease 
inhibitors cocktail. 
The sample is then dialyzed against 5 liters of the same buffer using a dialysis 
tubing (12 to 14 KD cutoff). The buffer was changed twice. 
After dialysis, the sample is centrifugated at 100,000g for one hour. The 
supernatant is loaded onto a 500 ml DEAE Sepharose column Fast flow column 
(Amersham biosciences) pre equilibrated with buffer B. 
After binding of proteins and equilibration of the column (flat base lane), bound 
proteins were eluted with a salt gradient (buffer C: 25 mM Tris-HCl (pH 7.4), 500 
mM KCl, 1mM DTT, 10% (w/v) Glycerol). Fractions containing coatomer were 
diluted to lower the salt concentration to 200 mM. Column was operated at 10 
Material and Methods 78
ml/min. 
The sample was then loaded onto a 6 ml Resource Q column (Amersham 
biosciences) equilibrated in the buffer B. After exhange of proteins on the resin 
and reaching base lane, a salt gradient allows elution of coatomer at 350 to 400 
mM KCl with purity up to 60%. 
Coatomer containing fractions were pooles and diluted to lower the salt 
concentration to 200 mM. Therefore, an additional Resource Q column (5 ml) 
was used to concentrate coatomer. Fractions were analyzed by SDS-PAGE and 
stained with Coomassie and coatomer is typically 50 to 60% pure. 
 
8.2 Endogenous yeast TAP-tagged coatomer 
 
A yeast strain TAP-tagged on the γ-cop coatomer subunit was purchased from 
Cellzome. 
Yeast was grown in 2 liters YPD in 5 l flask with “breakers” to OD 3.5 - 4.0. They 
were then  harvested and the pellet was washed with water. In addition, pellet 
was washed with LB Buffer. 
 
Subsequent to the wash, pellet was resuspended in 25ml LB in presence of 
0.5mM PMSF and 1 mM DTT and lysed with 25 ml glass beads (0.45 - 0.5 mm) 
into cold lysis container. The sample was recovered with a 50 ml syringe 
(LUERLOCK) over a 50 ml Falcon tube with a funnel and the lysate was pressed 
into the Falcon tube while beads stay in the syringe. The beads were washed 
with 10 ml LB (adding it to the beads in the syringe and pressing it through). 
Lysate was then spun at 4,000 rpm for 10 min at 4°C. The supernatant was 
transfered to ultracentrifuge tube and spun in a TI70 rotor for 1h at 100,000 g. 
The fatty top phase was removed with a water pump and the lysate transferred 
with 10 ml pipette to a Falcon tube. Glycerol was added to final concentration of 
5%(w/v). 
 
 First affinity purification with IgG beads 
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IgG beads (0.5 ml slurry) were washed with cold LB 3x times in a Falcon tube 
and added to the lysate. An additional Incubation for 1h at 4°C was carried out on 
a turning wheel. The sample was spun at 1,800 rpm for 3min at 4°C and the 
supernatant was removed. 
The beads were then transferred to mobicol (purchased from Mobitec) and a 
syringe was screwd to the Mobicol. Beads were washed with 10 ml LB + 0.5 mM 
DTT. 
 TEV cleavage 
A volume of 150 µl LB (+ 0.5 mM DTT) was added to the beads as well as 4 µl 
TEV (1 mg/ml). Digestion is complete after 2 hours at 16°C on a turning wheel. 
After cleavage, the eluate is recovered in 150 µl. 
 
 Second affinity purification with calmodulin Beads 
Calmodulin beads were prepared as follows, 
A volume of 600 µl slurry was washed with LB supplemented with 2 mM CaCl2 
and 1 mM DTT. Washed beads were transfered to mobicol and 150 µl LB + 4 
mM CaCl2 + 1 mM DTT and incubated with the TEV eluate (150 µl) for 1hour at 
4°C on a turning wheel. Mobicol was connected to a 10 ml syringe and beads 
were washed by adding 5 ml LB + 2 mM CaCl2 to the syringe. 
 
 Elution of affinity purified coatomer 
A volume of 600 µl elution buffer (10 mM TrisHCl, pH 8.0, 5 mM EGTA) was 
added to the beads and after 10 minutes incubation at 37°C, protein was eluted 
using a 3 ml syringe. 
 
 Gel filtration of purified coatomer 
The TAP-Tagged coatomer complex was polished further by size exclusion 
chromatography on a Superose6 (Amersham biosciences) following the 
manufacturer reommendations. The column was calibrated by runing 
Thyroglobulin, 660 KD; Alcohol dehydrogenase 150 KD; Ovalbumin, 45 KD; and 
Lysosyme, 14.5 KD as standard proteins. 
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8.3 Recombinant yeast ARF1p 
 
Bl21 (DE3) STAR cells were cotransformed with 1 µl pET24a-ARF1p and 1µl 
pACYC-Duet1-NMT1 plasmids and plated. A single colony was grown in 5 ml LB 
in presence of Kanamycine (50 µg/µl) and chloramphenicol (34 µg/µl) and served 
as a preculture for 1 liter culture. Cells were grown untill OD= 0.2-0.4 before 
addition of myristic acid. They were further grown untill OD= 0.6 and then 
induced with 1 mM IPTG at 27°C. When the bicistronic construct containing 
ARF1p and NMT1 genes was used, the same conditions were used and only 
chloramphenicol was added (34 µg/µl). 
Cells were centrifuged and the bacterial pellet was resuspended in MES buffer 
(25 mM MES, 1mM DTT, 5µM GDP, 1mM MgCl2, pH=5.7) (buffer A). Cells were 
lysed and centrifuged at 30,000g for 15 minutes and 100,000g for 1 hour. The 
supernatant containing soluble proteins was precipitated with Ammonium sulfate 
at 35% saturation. Myristoylated ARF1p precipitates while its non-myristoylated 
counterpart remains soluble.  
The precipitate is pelleted, resuspended in buffer A and desalted over a gel 
filtration column (PD10 Amersham biosciences). Two passages through this 
column allow removal of 99.75 % of the ammonium sulfate. 
ARF1p has a PI of 7.46 and at the pH of buffer A (pH = 5.7), the protein is 
positively charged and can be purified by cation exchange chromatography 
(Source-S (Amersham biosciences)). After equilibration in buffer A and loading 
the column with its counter ion (Na+) in buffer B, the protein sample is loaded and 
the flow through is collected for control. Most of the proteins do not bind to the 
column at that pH. The column was equilibrated with buffer A until reaching the 
baseline and subjected to a NaCl linear gradient. 
 
8.4 Recombinant human ARF1 
 
The same purification procedure described above for yeast ARF1p was applied 
except that the plasmids used were pbb131 (that contains NMT1 gene and has a 
resistance for Kanamycin) and pET11d-hARF1 (has resistance for Ampilcilin). 
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8.5 Recombinant Glo3p 
 
BL21(DE3) star bacteria were transformed with pET15a-Glo3p plasmid and 
plated on an LB-agar plate containing 100 µl/ml Ampicilin. A single colony was 
grown in LB medium in presence of Ampicilin (100µg/ml). One liter culture was 
inoculated and grown. When cells density reached OD= 0.6, expression was 
induced with 1 mM IPTG.  
The post-lysate pellet was resuspended in 8 M urea and pelleted again and 
Glo3p-His was purified from the soluble fraction by affinity chromatography over 
Nickel-Agarose beads (Novagen) and eluted with 250 mM Imidazole in presence 
of 8 M urea (Fig. 9, panel A). The protein concentration was adjusted to 0.1mg/ml 
and the buffer was exchanged to Hepes buffer (25 mM Hepes, 150 mM KOAc, 
1mMDTT, 100 µM ZnCl2, 20% glycerol, pH 7.2) by the usage of PD10 column 
(Amersham biosciences). 
 
8.6 Recombinant human p23 
 
Origami (DE3) cells (that have mutations in both the thioredoxin reductase (trxB) 
and glutathione reductase (gor) genes, which greatly enhances disulfide bond 
formation in the cytoplasm) pET-32 Xa/LIC-p23 purified over Nickel beads 
(Novagen). Origami bacteria were transformed with1 µl pET-32 Xa/LIC-p23 
plasmid and plated on an LB-agar plate containing 100µl/ml Ampicilin. A single 
colony was grown in LB medium in presence of Ampicilin (100µg/ml) at 37°C. 
One liter culture was inoculated and grown. When cells density reached OD= 0.6, 
expression was induced with 1 mM IPTG, cells were transftered to 16°C and 
protein expression was induced with 1 mM IPTG over night. Cells were harvested 
and resuspended in lysis buffer (50 mM Na2HPO4 pH 8, 400mM NaCl, 10 mM 
Imidazole, 4% (w/v) Triton X-100)). Cells were then broken after 3 passages 
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through a cell disrupter (Avestin EmulsiFlex-C5) at a pressure of 10,000 to 
15,000 psi. The lysate was centrifuged once at 30,000g for 15 minutes followed 
by a centrifugation at 100,000g for 1 hour. The soluble material was incubated 
with 0.5 ml Nickel beads previously washed with the lysis buffer. After 1 hour 
incubation, beads were pelleted (5 minutes at 500g) and the supernatant 
removed. Beads were washed with 50 mM Na2HPO4 pH 8, 400mM NaCl, 10 mM 
Imidazole, 1% (w/v) OG (20 ml). Two additional washes with the same buffer 
containing 20 mM and 50 mM Imidazole respectively, were performed. The 
bound protein was eluted with 50 mM Na2HPO4 pH 8, 400mM NaCl, 250 mM 
Imidazole, 1% (w/v) OG. Samples could be stored for 4 days at 4°C without 
apparent precipitation. 
8.7 Recombinant yeast SNAREs 
 
SNAREs were cloned into pGEX vector (Amersham Biosciences) as GST fusion 
proteins and purified using Glutathione Sepharose 4 Fast flow beads (Amersham 
Bioscoiences) under the manufacturer recommendations. 
Bl21 (DE3) STAR cells were transformed with 1 µl pGEX2T-SNAREs, plated in 
LB-Agar Petri dishes containing 100µg/ml Ampicilin and incubated at 37°C over 
night. One single clone was picked to start a pre culture in 5 ml LB. 1 liter LB was 
inoculated with this pre culture and grown at 37 °C until OD= 0.5-0.6. Protein 
expression was then induced by addition of 0.1 mM IPTG for 3 hours. 
Bacterial cells were pelleted and resuspended in PBS buffer supplemented with 
4% (v/v) Triton X-100 and protease inhibitor tablets (1 tablet for 50 ml). Cells 
were then broken after 3 passages through a cell disrupter (Avestin EmulsiFlex-
C5) at a pressure of 10,000 to 15,000 psi. The lysate was centrifuged once at 
30,000g for 15 minutes followed by a centrifugation at 100,000g for 1 hour. The 
supernatant was incubated with 500µl Glutathione Sepharose beads, previously 
washed in PBS + 4% Triton X-100, at 4 °C for 1 hour. GST fusion SNAREs bind 
to the Glutathione Sepharose beads under these conditions. Beads were 
sedimented. (500g for 5 minutes) and washed with PBS supplemented with 1 % 
(w/v) OG (5 ml to each 1 ml slurry). After 5 minutes agitation on a rotating wheel, 
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the beads were pelleted again and the supernatant removed. This procedure was 
repeated three times. Bound GST-SNAREs were eluted from the beads by 
adding 0.5 ml 50 mM Tris-HCl, 20 mM reduced Glutathione, 1% (w/v) OG, pH 8. 
Four elutions of 0.5 ml each were collected.   
8.8 Thrombin cleavage of GST fusion proteins 
 
Thrombin (Amersham Biosciences) was dissolved in cold PBS (500 Units in 500 
µl) and aliquots of 80 Units were frozen and kept at -80°C until usage. Ten Units 
of thrombin were added to each mg of fusion protein. The reaction took place at 
room temperature for 2 to 16 hours. 
9 SDS-PAGE and Western Blot analysis 
9.1 SDS-PAGE for separation of proteins 
Gels for SDS-PAGE were prepared according to the guidelines of Molecular 
cloning (3rd ed.). 12% and 14% separation gels were used in this experimental 
work or 12% and 4-12% pre-cast separation gels commercially available from 
Invitrogen. After electrophoresis, the gels were stained in coomassie blue 
solution and destained. For radioactive gels, after staining, the gels were dried 
and exposed to a film. Other gels were used for western blot analysis of the 
proteins of interest. 
9.2 Transfer proteins from SDS-PAGE to a PVDF membrane 
 or Nitrocellulose  
 
After performing SDS-PAGE, the proteins were electro-transferred to PVDF 
membranes (Immobilon-P® Milipore). The PVDF-membrane was submerged in 
methanol prior to soaking in the Anode buffer II. In semi-dry blotting 
discontinuous buffer system is used, composed of two anode buffers and one 
cathode buffer. The SDS-PAGE gel and PVDF membrane were arranged as 
follows: 2 sheets of Whatman 3MM filter paper pre-soaked in Anode buffer I were 
placed on the platinum anode, followed by 2 sheets of Whatman paper pre-
soaked in Anode buffer II, the PVDF-membrane, the gel, and firmly 3  sheets of 
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Whatman paper pre-soaked in Cathode buffer on top. The air was removed 
carefully by rolling out the air bubbles either by using a pipette or a 50ml tube. 
The cathode was placed on the stack and the blotting was executed at 24V for 
1.5 hrs. 
 
9.3 Incubation of PVDF membranes with antibodies 
 
Once the transfer was completed, the PDVF membrane was rinsed in water and 
stained with a Ponseau S solution. Excess of Ponseau S dye was washed away 
with water until protein marker bands appeared on the membrane and their 
positions could be marked on the membrane. The markers used throughout most 
of the thesis were broad range protein marker from Bio-Rad. The size of the 
protein markers is outlined in Table 3. 
 
Protein Molecular mass (kD) 
Myosin 200 
β-galactosidase 116 
Phosphorylase-b 97 
Serum albumin 66 
Ovalbumin 45 
Carbonic anhydrase 31 
Trypsin inhibitor 21 
Lysozyme 14 
Aprotinin 6.5 
 
                              Table 3: Protein standards (Broad Range) 
 
The PVDF membrane was blocked with 50 ml of 5% BSA in PBS for 1 hr at room 
temperature or overnight at 4°C. The blot was rinsed for 1min in PBS to remove 
BSA and incubated with the diluted primary antibodies (in 1% BSA PBS-T) for 1 
hr at room temperature, followed by washing  3 times with  PBST for 15 min. The 
blot was incubated with the HRP-conjugated secondary antibodies (1/5000 
dilution) or HRP-conjugated Protein-G (1/1000 dilution) in 50 ml 1% BSA in PBST 
for 1 hr at room temperature. The blot was washed 3 times with PBST for 15 min 
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and developed using ECL® western blotting detection system (Amersham-
Biotech). 
10 Protein Determination 
10.1 Protein Determination by BCA 
 
For soluble protein determination the BCA protein assay was employed (Pierce). 
All samples, including a set of standards (BSA: 2.5 µg, 5.0 µg, 10 µg, 15 µg, 20 
µg, 25 µg, 30 µg and 35 µg), were prepared in aqueous solution.  For 10 µl of 
each sample 200 µl of working reagent was added. The solution was prepared by 
mixing 50 parts of Reagent A with 1 part of Reagent B. The samples, including 
standards and blanks, were incubated at 37°C for 30 min, followed by 
measurement of absorbance at 562nm on a plate reader. 
10.2 Protein Determination by Lowry 
 
Lowry Solution A: 2 g Na2-tartrate Dissolved in 500 ml 1N NaOH,   
   100 g N2CO3   adjusted to 1 L with MiliQ water 
Lowry Solution B: 2 g Na2-tartrate Dissolved in 90 ml H2O, 10ml NaOH 
   1 g CuSO4x 5H2O adjusted to 500 ml with MiliQ water 
Lowry Solution C: Folin-Cicocalteus. Reagent prepared prior to use by  
      diluting 1/10 with MiliQ water 
 
Protein determination for membrane protein was performed according to Lowry. 
The protein standards were prepared with BSA (2.5 µg, 5.0 µg, 10 µg, 15 µg, 20 
µg, 25 µg, 30 µg and 35 µg) dissolved in water. The samples and standards were 
prepared by adding 10 µl of deoxycholate stock solution (Stock solution: Sodium 
deoxycholate 2 mg/ml) to 50 ul of sample. 150 µl of TCA (10%) (TriChloroacetic 
acid) were added to the sample, vortexed and centrifuged for 10 min at 14000 
rpm. The supernatant was removed, and 10 µl of SDS were added, followed by 
50 µl of Lowry solution A. The sample was incubated at 50oC for 10min, and 
cooled down for 3min to room temperature. 10 µl of Lowry solution B was added, 
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and the sample incubated for 15min at room temperature. 150 µl of Lowry 
solution C were added, and the sample was placed at 50oC for 10 min. Once the 
sample was at room temperature again, the absorbance was measured at 620nm 
on a plate reader. 
 
11 Protein Precipitation  
11.1 Chloroform-Methanol Precipitation 
 
Chloroform-Methanol Solution 1:2 20 ml CHCl3: 40 ml CH3OH 
One volume of sample was mixed with 3 volumes of Chloroform-Methanol 
solution. The mix was vortexed until the solution was clear (1 or 2 drops of 
methanol were added when the solution did not become clear). The sample was 
centrifuged 14000 rpm for 15min at 15oC. The supernatant was discarded and 
the pellet was dried for 1hr at 37oC or overnight at room temperature. The pellet 
was dissolved by adding Sample cocktail. Once dissolved, the sample was 
suitable for protein determination and/or protein electrophoresis. 
11.2 TCA precipitation  
 
TCA solution 72% (w/v)  
Sodium deoxycholate 2%  
Acetone   kept at -20oC 
 
The protein sample was diluted to a final volume of 1ml with MilliQ water, 
followed by addition of 16.7 µl of 2% sodium deoxycholate. The sample was 
vortexed and incubated for 15min at room temperature. 100 µl of TCA solution 
72% was added to the sample and vortexed, and then centrifuged for 7 min at 
10,000g. The supernatant was aspirated and 1ml of acetone at -20 added to 
wash the pellet. The sample was centrifuged as described above, and the pellet 
was allowed to dry. 
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